Amedeo Smart

Free Medical Literature Service


 

Amedeo

Otorhinolaryngology

  Free Subscription

Articles published in
Head Neck
    September 2021
  1. VAN DER ELST S, Bardash Y, Wotman M, Kraus D, et al
    The prognostic impact of depression or depressive symptoms on patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2021 Sep 15. doi: 10.1002/hed.26868.
    >> Share

  2. KU PKM, Vlantis AC, Hui TSC, Yeung DCM, et al
    Assessment of pharyngeal motor function using a novel velopharyngeal squeeze maneuver and a novel endoscopic pharyngeal contraction grade scale in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 15. doi: 10.1002/hed.26871.
    >> Share

  3. GAO Y, Mao Y, Lu S, Tan L, et al
    Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 13. doi: 10.1002/hed.26867.
    >> Share

  4. METZGER K, Mrosek J, Zittel S, Pilz M, et al
    Treatment delay and tumor size in patients with oral cancer during the first year of the COVID-19 pandemic.
    Head Neck. 2021 Sep 8. doi: 10.1002/hed.26858.
    >> Share

  5. SINGH P, McDonald L, Waldenberger D, Welslau M, et al
    Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and Germany.
    Head Neck. 2021 Sep 6. doi: 10.1002/hed.26853.
    >> Share

  6. SINGH A, Rosen EB, Randazzo JD, Estilo CL, et al
    Intraoral radiation stents-Primer for clinical use in head and neck cancer therapy.
    Head Neck. 2021 Sep 4. doi: 10.1002/hed.26848.
    >> Share

  7. FOLEY J, Ward EC, Burns CL, Nund RL, et al
    Speech pathology service enhancement for people with head and neck cancer living in rural areas: Using a concept mapping approach to inform service change.
    Head Neck. 2021 Sep 3. doi: 10.1002/hed.26850.
    >> Share

  8. HORWICH P, Gundale A, Patin S, Flores J, et al
    Impact of smoking on stage-specific survival in human papilloma virus-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2698-2704.
    >> Share

  9. YU L, Zheng M, Ren J, Hu J, et al
    Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for patients with laryngeal cicatricial stenosis: Safety and efficacy.
    Head Neck. 2021;43:2634-2643.
    >> Share

    August 2021
  10. GEARING PF, Daly JF, Tang NSJ, Singh K, et al
    Risk factors for surgical site infection in free-flap reconstructive surgery for head and neck cancer: A retrospective Australian cohort study.
    Head Neck. 2021 Aug 18. doi: 10.1002/hed.26837.
    >> Share

  11. BHOLA NE, Njatcha C, Hu L, Lee ED, et al
    PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance.
    Head Neck. 2021 Aug 3. doi: 10.1002/hed.26827.
    >> Share

  12. HAYDEN RE, Chang BA, Mullin DP, Patel AK, et al
    Reply to Letter to the Editor regarding "Surgical armamentarium for salvage laryngectomy closure reinforcements".
    Head Neck. 2021;43:2559.
    >> Share

  13. HOLCOMB AJ, Herberg M, Strohl M, Ochoa E, et al
    Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2434-2444.
    >> Share

  14. STEINBICHLER TB, Wolfram D, Runge A, Hartl R, et al
    Modified vacuum-assisted closure (EndoVAC) therapy for treatment of pharyngocutaneous fistula: Case series and a review of the literature.
    Head Neck. 2021;43:2377-2384.
    >> Share

    July 2021
  15. STOKES WA, Molina E, McDermott JD, Morgan RL, et al
    Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26809.
    >> Share

  16. SCHLIJPER R, Bos S, Hamilton SN, Tran E, et al
    Ninety-day mortality after radiotherapy for head and neck cancer: A population-based comparison between rural and urban patients.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26819.
    >> Share

  17. KIM MJ, Back K, Choe JH, Kim JH, et al
    Feasibility of lateral sentinel lymph node biopsy in medullary thyroid cancer: A surrogate tool for determining prophylactic lateral neck dissection-A pilot study.
    Head Neck. 2021 Jul 20. doi: 10.1002/hed.26808.
    >> Share

  18. DIAO K, Nguyen TP, Moreno AC, Reddy JP, et al
    Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: A large, single-institution, modern cohort study.
    Head Neck. 2021 Jul 16. doi: 10.1002/hed.26820.
    >> Share

  19. THANKAPPAN K, Subramanian S, Balasubramanian D, Kuriakose MA, et al
    Cost-effectiveness of oral cancer screening approaches by visual examination: A systematic review.
    Head Neck. 2021 Jul 14. doi: 10.1002/hed.26816.
    >> Share

  20. DING Z, Li Y, Pan X, Xuan M, et al
    Sentinel lymph node biopsy versus elective neck dissection in squamous cell carcinoma of the oral cavity with a clinically N0 neck: A systematic review and meta-analysis of prospective studies.
    Head Neck. 2021 Jul 10. doi: 10.1002/hed.26803.
    >> Share

  21. SHIGA K, Nibu KI, Fujimoto Y, Asakage T, et al
    Sites of invasion of cancer of the external auditory canal predicting oncologic outcomes.
    Head Neck. 2021 Jul 9. doi: 10.1002/hed.26800.
    >> Share

  22. REID P, Staudacher AH, Marcu LG, Olver I, et al
    Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26802.
    >> Share

  23. BADDOUR K, Fadel M, Zhao M, Corcoran M, et al
    The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26801.
    >> Share

  24. CHILLAKURU Y, Benito DA, Strum D, Mehta V, et al
    Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2259-2273.
    >> Share

  25. PFISTER NT, Beitler JJ, Stokes WA
    Contralateral nodal spread in human papillomavirus-associated oropharyngeal cancer: Can more details help guide contralateral neck coverage?
    Head Neck. 2021;43:2253.
    >> Share

  26. HUSAIN S, Lohia S, Petkov V, Blackwell T, et al
    Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.
    Head Neck. 2021;43:2110-2123.
    >> Share

  27. CHEN L, Lin G, Qian J, Chen Z, et al
    A dynamic prognostic nomogram to predict the benefit from surgical treatment modality for patients with laryngeal squamous cell carcinoma.
    Head Neck. 2021;43:2148-2158.
    >> Share

  28. TOMBLINSON CM, Fletcher GP, Hu LS, Mi L, et al
    Determination of posterolateral oropharyngeal wall thickness and the potential implications for transoral surgical margins in tonsil cancer.
    Head Neck. 2021;43:2185-2192.
    >> Share

  29. SAIYED FK, Guo T, Johnson F, Myers JN, et al
    Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2101-2109.
    >> Share

  30. CHARTERS E, Wu R, Milross C, Bogaardt H, et al
    Swallowing and communication outcomes following primary transoral robotic surgery.
    Head Neck. 2021;43:2013-2023.
    >> Share

  31. LASKAR SG, Pai P, Sinha S, Budrukkar A, et al
    Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single institute.
    Head Neck. 2021;43:2045-2057.
    >> Share

    June 2021
  32. GAO J, Tseng CC, Barinsky GL, Povolotskiy R, et al
    Exploratory analysis on the association of mental health disorders with in-hospital postoperative complications and mortality in head and neck cancer surgery.
    Head Neck. 2021 Jun 28. doi: 10.1002/hed.26791.
    >> Share

  33. BURBURE N, Handorf E, Ridge JA, Bauman J, et al
    Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer.
    Head Neck. 2021 Jun 24. doi: 10.1002/hed.26793.
    >> Share

  34. FATEHI KS, Malik A
    Elective neck dissection and its extent in salivary gland cancers: A dilemma.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26777.
    >> Share

  35. WESTERGAARD-NIELSEN M, Godballe C, Eriksen JG, Larsen SR, et al
    Reply to Letter to the Editor regarding "Elective neck dissection and its extent in Salivary gland cancers: A Dilemma".
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26778.
    >> Share

  36. RICH BJ, Schumacher LD, Sargi ZB, Masforroll M, et al
    Opioid use patterns in patients with head and neck cancer receiving radiation therapy: A single-institution retrospective analysis characterizing patients who did not require opioid therapy.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26785.
    >> Share

  37. WEIZMAN B, Golan N, Ronen O
    Effect of socioeconomic status on survival in patients with head and neck cancer.
    Head Neck. 2021 Jun 16. doi: 10.1002/hed.26788.
    >> Share

  38. BERGAMINI C, Ferris RL, Xie J, Mariani G, et al
    Bleeding complications in patients with squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Jun 12. doi: 10.1002/hed.26772.
    >> Share

  39. CAVALHEIRO BG, de Matos LL, Leite AKN, Kulcsar MAV, et al
    Survival in differentiated thyroid carcinoma: A comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system.
    Head Neck. 2021 Jun 1. doi: 10.1002/hed.26773.
    >> Share

  40. SABIQ F, Huang K, Patel A, Banerjee R, et al
    Novel imaging classification system of nodal disease in human papillomavirus-mediated oropharyngeal squamous cell carcinoma prognostic of patient outcomes.
    Head Neck. 2021;43:1854-1863.
    >> Share

  41. SAMPLE RA, Wood CB, Mazul AL, Barrett TF, et al
    Low-risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: Equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone.
    Head Neck. 2021;43:1759-1768.
    >> Share

  42. YAVUZ H, Vural O
    Tracheoesophageal puncture closure with annular mucosal flap.
    Head Neck. 2021;43:1705-1710.
    >> Share

    May 2021
  43. FAGAN JJ, Otiti J, Onakoya PA, Diom E, et al
    AfHNS fellowship: A model to improve access to head and neck cancer care in Africa and developing countries.
    Head Neck. 2021 May 29. doi: 10.1002/hed.26770.
    >> Share

  44. YANG S, Yuan ZJ, Zhu YH, Chen X, et al
    lncRNA PVT1 promotes cetuximab resistance of head and neck squamous cell carcinoma cells by inhibiting miR-124-3p.
    Head Neck. 2021 May 25. doi: 10.1002/hed.26742.
    >> Share

  45. CIVANTOS AM, Prasad A, Carey RM, Bur AM, et al
    Palliative care in metastatic head and neck cancer.
    Head Neck. 2021 May 21. doi: 10.1002/hed.26761.
    >> Share

  46. GOSHTASBI K, Abiri A, Lehrich BM, Haidar YM, et al
    The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26739.
    >> Share

  47. PANG J, Faraji F, Risa E, Mell LK, et al
    High rates of postoperative radiotherapy delay in head and neck cancer before and after Medicaid expansion.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26736.
    >> Share

  48. HOESSEINI A, van Leeuwen N, Offerman MPJ, Zhang J, et al
    Predicting survival in head and neck cancer: External validation and update of the prognostic model OncologIQ in 2189 patients.
    Head Neck. 2021 May 7. doi: 10.1002/hed.26716.
    >> Share

  49. RIJO-CEDENO J, Mucientes J, Seijas Marcos S, Romero J, et al
    Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26725.
    >> Share

  50. VERMAIRE JA, Terhaard CHJ, Verdonck-de Leeuw IM, Raaijmakers CPJ, et al
    Reliability of the 100 mL water swallow test in patients with head and neck cancer and healthy subjects.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26723.
    >> Share

  51. LIAO W, He J, Gou Q, Duan B, et al
    Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26706.
    >> Share

  52. CHANG JW, Lee S, Lee JM, Moon IS, et al
    Occult parotid involvement in early-stage squamous cell carcinoma of the external auditory canal.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26729.
    >> Share

  53. OTTENSTEIN L, Cornett H, Switchenko JM, Nathan M, et al
    Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.
    Head Neck. 2021;43:1629-1640.
    >> Share

  54. LIM Y, Tang KD, Karpe AV, Beale DJ, et al
    Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer.
    Head Neck. 2021;43:1521-1534.
    >> Share

  55. YOUNG A, Bigcas JL, Yang A, Reeve N, et al
    Transoral robotic submandibular gland transposition to reconstruct radical tonsillar resection defects.
    Head Neck. 2021;43:1695-1698.
    >> Share

  56. SMITH AW, Gallitto M, Lehrer EJ, Wasserman I, et al
    Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era.
    Head Neck. 2021;43:1409-1414.
    >> Share

  57. MOLTENI G, Gazzini L, Sacchetto A, Nocini R, et al
    Role of the temporoparietal fascia free flap in salvage total laryngectomy.
    Head Neck. 2021;43:1692-1694.
    >> Share

  58. LIU HY, Daniels CP, Trada Y, Bernard A, et al
    The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2021;43:1440-1450.
    >> Share

  59. NOCON CC, Kuchta K, Bhayani MK
    Prognostic value of lymph node ratio versus American Joint Committee on Cancer N classification for surgically resected human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:1476-1486.
    >> Share

    April 2021
  60. XU H, Lu L, Lu T, Xu Y, et al
    Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 Apr 27. doi: 10.1002/hed.26726.
    >> Share

  61. HIGHLAND J, Aylward A, Do O, Monroe M, et al
    Trust in physicians among patients with head and neck cancer before and after treatment.
    Head Neck. 2021 Apr 26. doi: 10.1002/hed.26721.
    >> Share

  62. SEKI-SODA M, Sano T, Ogawa M, Yokoo S, et al
    CD15(+) tumor infiltrating granulocytic cells can predict recurrence and their depletion is accompanied by good responses to S-1 with oral cancer.
    Head Neck. 2021 Apr 24. doi: 10.1002/hed.26712.
    >> Share

  63. NUYTS S, Bollen H, Eisbruch A, Corry J, et al
    Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Apr 19. doi: 10.1002/hed.26713.
    >> Share

  64. MESSING BP, Ward EC, Lazarus C, Ryniak K, et al
    Longitudinal comparisons of a whole-mouth taste test to clinician-rated and patient-reported outcomes of dysgeusia postradiotherapy in patients with head and neck cancer and associations with oral intake.
    Head Neck. 2021 Apr 15. doi: 10.1002/hed.26690.
    >> Share

  65. WANG SM, Yin SC, Su XZ, Xu Q, et al
    Magnitude of radial forearm free flaps and factors associated with loss of volume in oral cancer reconstructive surgery: A prospective study.
    Head Neck. 2021 Apr 13. doi: 10.1002/hed.26704.
    >> Share

  66. WIBONELE BK, Smith BD, Altonji S, Kaplan S, et al
    Head and neck cancer research collaborations between the United States and low- and middle-income countries: A 10-year publication analysis.
    Head Neck. 2021 Apr 5. doi: 10.1002/hed.26703.
    >> Share

  67. YANG N, Mercier E, Guertin L, Bissada E, et al
    Development, translation, and preliminary validation of the neck dissection assessment tool.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26696.
    >> Share

  68. SMITS HJG, Assili S, Kauw F, Philippens MEP, et al
    Prognostic imaging variables for recurrent laryngeal and hypopharyngeal carcinoma treated with primary chemoradiotherapy: A systematic and meta-analysis.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26698.
    >> Share

  69. MILINIS K, Gaskell P, Lau A, Lancaster J, et al
    Early versus late oral feeding following total (pharyngo)laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2021;43:1359-1368.
    >> Share

  70. XING MH, Mundi N, Govindan A, Khorsandi A, et al
    Unusual location of a second branchial cleft cyst presenting in the suprasternal notch.
    Head Neck. 2021;43:E27-E29.
    >> Share

  71. ATALLAH I, Castellanos PF
    Transoral closure of the supraglottic larynx for intractable aspiration.
    Head Neck. 2021;43:1370-1375.
    >> Share

  72. SINHA S, Agarwal JP, Mahajan A, Chaturvedi P, et al
    Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study.
    Head Neck. 2021;43:1289-1299.
    >> Share

  73. MCKENZIE RM, Parhar HS, Ng TL, Prisman E, et al
    Muscle invasion in oropharyngeal carcinoma undergoing transoral robotic surgery.
    Head Neck. 2021;43:1194-1201.
    >> Share

  74. MATTIOLI F, Fernandez IJ, Bassano E, Luppi MP, et al
    Surgical rehabilitation of swallowing with polydimethylsiloxane injections after open partial horizontal laryngectomy: Long-term functional results and quality of life.
    Head Neck. 2021;43:1161-1173.
    >> Share

  75. CAREY RM, Shimunov D, Weinstein GS, Cannady SB, et al
    Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy.
    Head Neck. 2021;43:1128-1141.
    >> Share

  76. SUN M, Wang K, Qu Y, Zhang J, et al
    Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
    Head Neck. 2021;43:1097-1104.
    >> Share

  77. KUMAR A, Laskar SG, Thiagarajan S
    Is Transoral Robotic Surgery (TORS) for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1376-1377.
    >> Share

  78. BATES JE, Amdur RJ
    In reply to Kumar et al, Is TORS for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1378-1379.
    >> Share

    March 2021
  79. GUAN H, He Y, Su Y, Wei Z, et al
    Assessment of different induction chemotherapy regimens in locally advanced nasopharyngeal carcinoma: A meta-analysis.
    Head Neck. 2021 Mar 31. doi: 10.1002/hed.26699.
    >> Share

  80. LI W, Lu H, Wang H, Hu L, et al
    Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis.
    Head Neck. 2021 Mar 29. doi: 10.1002/hed.26687.
    >> Share

  81. NG WT, Tsang RKY, Beitler JJ, de Bree R, et al
    Contemporary management of the neck in nasopharyngeal carcinoma.
    Head Neck. 2021 Mar 29. doi: 10.1002/hed.26685.
    >> Share

  82. EBERSOLE B, McCarroll L, Ridge JA, Liu JC, et al
    Identification and management of late dysfunction in survivors of head and neck cancer: Implementation and outcomes of an interdisciplinary quality of life (IQOL) clinic.
    Head Neck. 2021 Mar 21. doi: 10.1002/hed.26681.
    >> Share

  83. STADLER TM, Morand GB, Rupp NJ, Hullner MW, et al
    FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
    Head Neck. 2021 Mar 17. doi: 10.1002/hed.26668.
    >> Share

  84. SHAH R, Gosavi V, Mahajan A, Sonawane S, et al
    Preoperative prediction of parathyroid carcinoma in an Asian Indian cohort.
    Head Neck. 2021 Mar 10. doi: 10.1002/hed.26677.
    >> Share

  85. PATEL U, Mittal N, Rane SU, Patil A, et al
    Correlation of transcriptionally active human papillomavirus status with the clinical and molecular profiles of head and neck squamous cell carcinomas.
    Head Neck. 2021 Mar 10. doi: 10.1002/hed.26676.
    >> Share

  86. SAKA-HERRAN C, Jane-Salas E, Estrugo-Devesa A, Lopez-Lopez J, et al
    Head and neck cancer and non-steroidal anti-inflammatory drugs: Systematic review and meta-analysis.
    Head Neck. 2021 Mar 8. doi: 10.1002/hed.26663.
    >> Share

  87. SANSA A, Venegas MDP, Valero C, Pardo L, et al
    The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients.
    Head Neck. 2021 Mar 6. doi: 10.1002/hed.26673.
    >> Share

  88. FASSAS S, Cummings E, Sykes KJ, Bur AM, et al
    Telemedicine for head and neck cancer surveillance in the COVID-19 era: Promise and pitfalls.
    Head Neck. 2021 Mar 4. doi: 10.1002/hed.26659.
    >> Share

  89. WARREN EAK, Anil J, Castro PD, Kemnade J, et al
    Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.
    Head Neck. 2021 Mar 4. doi: 10.1002/hed.26662.
    >> Share

  90. BUGTER O, van Iwaarden DLP, van Leeuwen N, Nieboer D, et al
    A cause-specific Cox model for second primary tumors in patients with head and neck cancer: A RONCDOC study.
    Head Neck. 2021 Mar 3. doi: 10.1002/hed.26666.
    >> Share

  91. KIONG KL, Diaz EM, Gross ND, Diaz EM Jr, et al
    The impact of COVID-19 on head and neck cancer diagnosis and disease extent.
    Head Neck. 2021 Mar 2. doi: 10.1002/hed.26665.
    >> Share

  92. DICKSTEIN DR, Egerman M, Monrose E, Varma A, et al
    Treatment tolerability and outcomes in elderly patients with head and neck cancer.
    Head Neck. 2021;43:858-873.
    >> Share

  93. RITTER A, Hod R, Reuven Y, Shpitzer T, et al
    Role of intraoperative recurrent laryngeal nerve monitoring for pediatric thyroid surgery: Comparative analysis.
    Head Neck. 2021;43:849-857.
    >> Share

    February 2021
  94. LI M, Zhang B, Chen Q, Zhang L, et al
    Concurrent chemoradiotherapy with additional chemotherapy for nasopharyngeal carcinoma: A pooled analysis of propensity score-matching studies.
    Head Neck. 2021 Feb 28. doi: 10.1002/hed.26664.
    >> Share

  95. STEPAN KO, Mazul AL, Skillington SA, Paniello RC, et al
    The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.
    Head Neck. 2021 Feb 23. doi: 10.1002/hed.26639.
    >> Share

  96. VAN DER LANS RJL, Engel MSD, Rijken JA, Hensen EF, et al
    Neuroendocrine neoplasms of the middle ear: Unpredictable tumor behavior and tendency for recurrence.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26658.
    >> Share

  97. YANG K, Li M, Zhu J, Zeng L, et al
    Nomograms for predicting survival outcomes in intensity-modulated radiotherapy era of nasopharyngeal carcinoma: A study based on Epstein-Barr virus DNA biological responses.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26654.
    >> Share

  98. RAMSEY T, Lee B, Curran K, Desai V, et al
    Associations of insurance, urbanity, and comorbidity with types of palliative care received by patients with head and neck cancer.
    Head Neck. 2021 Feb 18. doi: 10.1002/hed.26648.
    >> Share

  99. RANGABASHYAM M, Koh SQ, Sultana R, Tan NC, et al
    Factors associated with returning to work in head and neck cancer survivors in Singapore: A preliminary exploratory mixed-methods approach study.
    Head Neck. 2021 Feb 18. doi: 10.1002/hed.26644.
    >> Share

  100. FUNG SYH, Chan KCA, Wong EWY, Ng CWK, et al
    Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26647.
    >> Share

  101. SABOUR S, Ghajari H
    Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma: Methodological issues.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26645.
    >> Share

  102. ELSHARAWI R, Antonucci E, Sukari A, Cramer JD, et al
    Quality metrics for head and neck cancer treated with definitive radiotherapy and/or chemotherapy.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26640.
    >> Share

  103. GUO J, Gui R
    Reply: Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma: Methodological issues (HED-20-22881).
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26652.
    >> Share

  104. USHINSKY A, Guevara CJ, Kim SK
    Intranodal lymphangiography with thoracic duct embolization for the treatment of chyle leaks after head and neck cancer surgery.
    Head Neck. 2021 Feb 15. doi: 10.1002/hed.26646.
    >> Share

  105. GRECO E, Ringash J, Tomlinson G, Huang SH, et al
    Presence and duration of feeding tube in a 5-year cohort of patients with head and neck cancer treated with curative intensity-modulated radiation therapy.
    Head Neck. 2021 Feb 13. doi: 10.1002/hed.26638.
    >> Share

  106. BURGIN SJM, Spector ME, Pearson AT, Bellile E, et al
    Long-term neck and shoulder function among survivors of oropharyngeal squamous cell carcinoma treated with chemoradiation as assessed with the neck dissection impairment index.
    Head Neck. 2021 Feb 12. doi: 10.1002/hed.26636.
    >> Share

  107. POON DMC, Kam MKM, Johnson D, Mo F, et al
    Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy.
    Head Neck. 2021 Feb 11. doi: 10.1002/hed.26634.
    >> Share

  108. ANG MK, Montoya JE, Tharavichitkul E, Lim C, et al
    A phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 5. doi: 10.1002/hed.26635.
    >> Share

  109. XIE G, Zhu A, Gu X
    Mitogen-activated protein kinase inhibition-induced modulation of epidermal growth factor receptor signaling in human head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 3. doi: 10.1002/hed.26633.
    >> Share

  110. ALVES LDB, Menezes ACS, Pereira DL, Santos MTC, et al
    Benefits of intraoral stents in patients with head and neck cancer undergoing radiotherapy: Systematic review.
    Head Neck. 2021 Feb 1. doi: 10.1002/hed.26620.
    >> Share

  111. HOLCOMB AJ, Richmon JD
    Transoral robotic salvage oropharyngectomy with submental artery island flap reconstruction.
    Head Neck. 2021;43:E13-E19.
    >> Share

  112. LAO WP, Lagabon KJ, Arom GA, Walker PC, et al
    Combined endoscopic and transoral resection of a high-staged juvenile nasopharyngeal angiofibroma: A pictorial essay.
    Head Neck. 2021;43:719-724.
    >> Share

  113. LE FLEM M, Santini L, Boulze C, Alshukry A, et al
    Reply to the Letter to the Editor regarding "Early oral hydration protects against pharyngocutaneous fistula after total laryngectomy or total pharyngolaryngectomy".
    Head Neck. 2021;43:718.
    >> Share

  114. BINZ GHA, Soyka MB, Holzmann D, Meerwein CM, et al
    Need for long-term follow-up in sinonasal inverted papilloma: A Single-institution experience.
    Head Neck. 2021;43:630-638.
    >> Share

  115. EDAFE O
    Impact of early oral hydration on pharyngocutaneous fistula following total laryngectomy.
    Head Neck. 2021;43:716-717.
    >> Share

  116. HUANG SH, de Almeida JR, Watson E, Glogauer M, et al
    Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma.
    Head Neck. 2021;43:456-466.
    >> Share

  117. SU WW, Lee YH, Yen AM, Chen SL, et al
    Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a nationwide screening program.
    Head Neck. 2021;43:473-484.
    >> Share

  118. BOS P, van den Brekel MWM, Gouw ZAR, Al-Mamgani A, et al
    Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer.
    Head Neck. 2021;43:485-495.
    >> Share

  119. HUANG TY, Lin YC, Tseng HY, Kim HY, et al
    Full percutaneous intraoperative neuromonitoring technique in remote thyroid surgery: Porcine model feasibility study.
    Head Neck. 2021;43:505-513.
    >> Share

    January 2021
  120. GISSI DB, Morandi L, Colella G, De Luca R, et al
    Clinical validation of 13-gene DNA methylation analysis in oral brushing samples for detection of oral carcinoma: An Italian multicenter study.
    Head Neck. 2021 Jan 28. doi: 10.1002/hed.26624.
    >> Share

  121. HOPKINS-ROSSABI T, Armeson KE, Zecker SG, Martin-Harris B, et al
    Respiratory-swallow coordination and swallowing impairment in head and neck cancer.
    Head Neck. 2021 Jan 25. doi: 10.1002/hed.26609.
    >> Share

  122. IQBAL MS, Kelly C, Kovarik J, McQueen A, et al
    Rapid recurrence in postoperative head and neck cancer: Underappreciated or overcalled problem?
    Head Neck. 2021 Jan 25. doi: 10.1002/hed.26615.
    >> Share

  123. POLCE S, Gogineni E, Antone J, Ghaly M, et al
    Dental radiation dosimetric maps from intensity-modulated radiation therapy planning for head and neck cancers.
    Head Neck. 2021 Jan 15. doi: 10.1002/hed.26611.
    >> Share

  124. WEI ZG, Hu XL, He Y, Guan H, et al
    Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA.
    Head Neck. 2021 Jan 9. doi: 10.1002/hed.26608.
    >> Share

  125. MAYS AC, Yarlagadda B, Achim V, Jackson R, et al
    Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer.
    Head Neck. 2021 Jan 8. doi: 10.1002/hed.26601.
    >> Share

  126. INGARFIELD K, McMahon AD, Hurley K, Toms S, et al
    Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort study.
    Head Neck. 2021 Jan 8. doi: 10.1002/hed.26589.
    >> Share

  127. BROEMER L, Friedrich M, Wichmann G, Muller J, et al
    Exploratory study of functional and psychological factors associated with employment status in patients with head and neck cancer.
    Head Neck. 2021 Jan 1. doi: 10.1002/hed.26595.
    >> Share

  128. HAYDEN RE, Chang BA, Mullin DP, Patel AK, et al
    Bipedicled submental musculofascial "hammock" flap for salvage laryngectomy closure reinforcement.
    Head Neck. 2021;43:198-202.
    >> Share

  129. SHARBEL DD, Abkemeier M, Sullivan J, Zimmerman Z, et al
    Transcervical arterial ligation for prevention of postoperative hemorrhage in transoral oropharyngectomy: Systematic review and meta-analysis.
    Head Neck. 2021;43:334-344.
    >> Share

  130. MOORE EJ, Van Abel KM, Routman DM, Lohse CM, et al
    Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
    Head Neck. 2021;43:229-237.
    >> Share

  131. CLARK CM, Newark AC, Fokar A, Maxwell JH, et al
    Aspirin use predicts prolonged survival in patients with oropharyngeal cancer: Nationwide Veterans Affairs database study.
    Head Neck. 2021;43:247-254.
    >> Share

  132. FUNG AS, Afzal AR, Banerjee R, Debenham B, et al
    A real-world comparison of cisplatin vs cetuximab used concurrently with radiation in the treatment of locally advanced oropharyngeal carcinoma.
    Head Neck. 2021;43:153-163.
    >> Share

  133. PANUGANTI BA, Stuart E, Weissbrod P
    Changes in treatment trends in the early glottic cancer population after the Affordable Care Act.
    Head Neck. 2021;43:137-144.
    >> Share

  134. CHWEYA CM, Low CM, Van Gompel JJ, Van Abel KM, et al
    Population-based analysis on the effect of nodal and distant metastases in sinonasal adenocarcinoma.
    Head Neck. 2021;43:128-136.
    >> Share

  135. ZEVALLOS JP, Kramer JR, Sandulache VC, Massa ST, et al
    National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System.
    Head Neck. 2021;43:108-115.
    >> Share

  136. THONG G, Brophy C, Sheahan P
    Use of intraoperative neural monitoring for prognostication of recovery of vocal mobility and reduction of permanent vocal paralysis after thyroidectomy.
    Head Neck. 2021;43:7-14.
    >> Share

    December 2020
  137. PANDIT PN, Patil RA, Palwe VS, Tambade SH, et al
    Patterns of blood pressure changes in patients with head and neck cancer receiving radiotherapy or chemo-radiotherapy at a tertiary cancer centre.
    Head Neck. 2020 Dec 29. doi: 10.1002/hed.26590.
    >> Share

  138. FANG R, Peng L, Chen L, Liao J, et al
    The survival benefit of lymph node dissection in resected T1-2, cN0 supraglottic cancer: A population-based propensity score matching analysis.
    Head Neck. 2020 Dec 29. doi: 10.1002/hed.26596.
    >> Share

  139. STARR N, Oyler DR, Schadler A, Aouad RK, et al
    Chronic opioid use after laryngeal cancer treatment.
    Head Neck. 2020 Dec 28. doi: 10.1002/hed.26591.
    >> Share

  140. RAO VUS, Subash A, R Bhargavi V, Sinha P, et al
    Selective embolization of lingual artery in transoral robotic surgery for the management of recurrent base of tongue carcinomas.
    Head Neck. 2020 Dec 24. doi: 10.1002/hed.26585.
    >> Share

  141. KISHIKAWA T, Suzuki M, Takemoto N, Fukusumi T, et al
    Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2020 Dec 23. doi: 10.1002/hed.26583.
    >> Share

  142. GARCIA-ANAYA MJ, Ordonez R, Toledo MD, Correa RC, et al
    Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy.
    Head Neck. 2020 Dec 15. doi: 10.1002/hed.26555.
    >> Share

  143. ANDERSON EM, Luu M, Balzer BL, Scher KS, et al
    Variations in the association of grade with survival across the head and neck cancer landscape.
    Head Neck. 2020 Dec 10. doi: 10.1002/hed.26566.
    >> Share

  144. CHEN G, Jiang H, Jiang D, Wu Q, et al
    Pretreatment serum vitamin level predicts severity of radiation-induced oral mucositis in patients with nasopharyngeal carcinoma.
    Head Neck. 2020 Dec 10. doi: 10.1002/hed.26576.
    >> Share

  145. SANDLER ML, Xing MH, Levy JC, Chai RL, et al
    Metastatic thyroid carcinoma to the parapharyngeal and retropharyngeal spaces: Systematic review with seven newly reported cases describing an uncommon presentation of a common disease.
    Head Neck. 2020 Dec 9. doi: 10.1002/hed.26572.
    >> Share

  146. CARNABY GD, Chhabria K
    Preliminary development and validation of a measure of fear of swallowing and swallowing-related movement injury in head and neck cancer: Swallowing Kinesiophobia Scale.
    Head Neck. 2020 Dec 2. doi: 10.1002/hed.26573.
    >> Share

  147. WORKMAN AD, Soylu S, Kamani D, Nourmahnad A, et al
    Limitations of preoperative cytology for medullary thyroid cancer: Proposal for improved preoperative diagnosis for optimal initial medullary thyroid carcinoma specific surgery.
    Head Neck. 2020 Dec 2. doi: 10.1002/hed.26550.
    >> Share

    November 2020
  148. YI X, Chen W, Li C, Chen X, et al
    Circular RNA circ_0004507 contributes to laryngeal cancer progression and cisplatin resistance by sponging miR-873 to upregulate multidrug resistance 1 and multidrug resistance protein 1.
    Head Neck. 2020 Nov 28. doi: 10.1002/hed.26549.
    >> Share

  149. ZHANG Z, Xia F, Wang W, Jiang B, et al
    Ambulatory thyroidectomy is safe and beneficial in papillary thyroid carcinoma: Randomized controlled trial.
    Head Neck. 2020 Nov 28. doi: 10.1002/hed.26557.
    >> Share

  150. RITTER A, Badir S, Mansour M, Segal Z, et al
    Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients.
    Head Neck. 2020 Nov 27. doi: 10.1002/hed.26546.
    >> Share

  151. AKALI NR, Buggaveeti R, Sukumaran SV, Balasubramanian D, et al
    Prior chemoradiotherapy and pathological perineural invasion predict the survival outcomes of salvage surgery in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 21. doi: 10.1002/hed.26547.
    >> Share

  152. JURICA JM, Rubio F, Hernandez DJ, Sandulache VC, et al
    Institutional financial toxicity of failure to adhere to treatment guidelines for head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 9. doi: 10.1002/hed.26539.
    >> Share

  153. CARRON J, Torricelli C, Silva JK, Queiroz GSR, et al
    microRNAs deregulation in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 6. doi: 10.1002/hed.26533.
    >> Share

  154. ADEOYE J, Wan CCJ, Thomson P
    Mock clinical testing in the validation of fluid-phase biomarkers for head and neck carcinoma diagnosis: A Scoping review.
    Head Neck. 2020 Nov 5. doi: 10.1002/hed.26526.
    >> Share

  155. YUAN X, Zhang L, Huang Y, Liu D, et al
    Induction of interleukin-6 by irradiation and its role in epithelial mesenchymal transition and radioresistance of nasopharyngeal carcinoma cells.
    Head Neck. 2020 Nov 5. doi: 10.1002/hed.26531.
    >> Share

  156. HU CY, Wang WM, Chu XH, Ren ZH, et al
    Global, regional, and national burden of nasopharyngeal carcinoma from 1990 to 2017-Results from the Global Burden of Disease Study 2017.
    Head Neck. 2020;42:3243-3252.
    >> Share

    October 2020
  157. MOSES LE, Oliver JR, Rotsides JM, Shao Q, et al
    Nodal disease burden and outcome of medullary thyroid carcinoma.
    Head Neck. 2020 Oct 27. doi: 10.1002/hed.26511.
    >> Share

  158. CAVALIERI S, De Cecco L, Brakenhoff RH, Serafini MS, et al
    Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.
    Head Neck. 2020 Oct 27. doi: 10.1002/hed.26515.
    >> Share

  159. MULDER FJ, Pierssens DDCG, Baijens LWJ, Kremer B, et al
    Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta-analysis on HPV, p16, and TP53.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26513.
    >> Share

  160. MARGALIT DN, Sacco AG, Cooper JS, Ridge JA, et al
    Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26490.
    >> Share

  161. LIU W, Qdaisat A, Zhou S, Fuller CD, et al
    Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26510.
    >> Share

  162. KONO M, Wakisaka R, Kumai T, Hayashi R, et al
    Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy.
    Head Neck. 2020 Oct 5. doi: 10.1002/hed.26502.
    >> Share

  163. GADKAREE SK, McCarty JC, Feng AL, Siu JM, et al
    Role of physician density in predicting stage and survival for head and neck squamous cell carcinoma.
    Head Neck. 2020 Oct 4. doi: 10.1002/hed.26495.
    >> Share

  164. WANG Z, Yuan H, Huang J, Hu D, et al
    Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Head Neck. 2020 Oct 3. doi: 10.1002/hed.26474.
    >> Share

  165. OKANO W, Hayashi R, Matsuura K, Shinozaki T, et al
    Extent of salvage neck dissection following chemoradiation for locally advanced head and neck cancer.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26494.
    >> Share

  166. KARATAS OF, Capik O, Barlak N, Aydin Karatas E, et al
    Comprehensive in silico analysis for identification of novel candidate target genes, including DHX36, OPA1, and SENP2, located on chromosome 3q in head and neck cancers.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26493.
    >> Share

  167. JEANS C, Ward EC, Brown B, Vertigan AE, et al
    Association between external and internal lymphedema and chronic dysphagia following head and neck cancer treatment.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26484.
    >> Share

  168. SYKES KJ, Morrow E, Smith JB, Holcomb AJ, et al
    What is the hold up?-Mixed-methods analysis of postoperative radiotherapy delay in head and neck cancer.
    Head Neck. 2020;42:2948-2957.
    >> Share

    September 2020
  169. SVAJDOVA M, Dubinsky P, Kazda T
    Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: Critical review.
    Head Neck. 2020 Sep 30. doi: 10.1002/hed.26485.
    >> Share

  170. BRENNAN MT, Treister NS, Sollecito TP, Schmidt BL, et al
    Epidemiologic factors in patients with advanced head and neck cancer treated with radiation therapy.
    Head Neck. 2020 Sep 29. doi: 10.1002/hed.26468.
    >> Share

  171. LEE DY, Abraham J, Ross E, Ridge JA, et al
    Rapid recurrence in head and neck cancer: Underappreciated problem with poor outcome.
    Head Neck. 2020 Sep 29. doi: 10.1002/hed.26479.
    >> Share

  172. LIU YP, Wang SL, Zou X, You R, et al
    Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence.
    Head Neck. 2020 Sep 28. doi: 10.1002/hed.26459.
    >> Share

  173. MHASKAR R, Caputo MP, Mifsud MJ
    Reply to Letter to the Editor regarding "Diabetes mellitus in major head and neck cancer surgery: Systematic review and meta-analysis".
    Head Neck. 2020 Sep 23. doi: 10.1002/hed.26446.
    >> Share

  174. HUANG GJ, Kong XY
    Diabetes mellitus in major head and neck cancer surgery.
    Head Neck. 2020 Sep 23. doi: 10.1002/hed.26451.
    >> Share

  175. KRIPLANI A, Lavery JA, Mishra A, Korenstein D, et al
    Trends in chronic opioid therapy among survivors of head and neck cancer.
    Head Neck. 2020 Sep 22. doi: 10.1002/hed.26478.
    >> Share

  176. LIAO AH, Lin WT, Chen HK, Shih CP, et al
    Synergistic effects of combined treatment with ultrasound-mediated cisplatin-loaded microbubbles and atorvastatin on head and neck cancer.
    Head Neck. 2020 Sep 21. doi: 10.1002/hed.26445.
    >> Share

  177. LUO Y, Ma J, Liu F, Guo J, et al
    Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma.
    Head Neck. 2020 Sep 18. doi: 10.1002/hed.26441.
    >> Share

  178. ZOLKIND P, Lee JJ, Jackson RS, Pipkorn P, et al
    Untreated head and neck cancer: Natural history and associated factors.
    Head Neck. 2020 Sep 11. doi: 10.1002/hed.26460.
    >> Share

  179. RIJO-CEDENO J, Mucientes J, Alvarez O, Royuela A, et al
    Metabolic tumor volume and total lesion glycolysis as prognostic factors in head and neck cancer: Systematic review and meta-analysis.
    Head Neck. 2020 Sep 11. doi: 10.1002/hed.26461.
    >> Share

  180. TAE K
    Reply to Letter to the Editor: Transoral robotic selective neck dissection for papillary thyroid carcinoma: Is it appropriate?
    Head Neck. 2020 Sep 5. doi: 10.1002/hed.26449.
    >> Share

  181. PICCIN O, D'Alessio P, Cavicchi O
    Transoral robotic selective neck dissection for papillary thyroid carcinoma: Is it appropriate?
    Head Neck. 2020 Sep 5. doi: 10.1002/hed.26447.
    >> Share

  182. HUANG GJ, Yang BB
    Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma.
    Head Neck. 2020 Sep 1. doi: 10.1002/hed.26388.
    >> Share

  183. ZHU X
    Reply to Letter to the Editor regarding "Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma through co-expression network analysis".
    Head Neck. 2020 Sep 1. doi: 10.1002/hed.26390.
    >> Share

    August 2020
  184. LOPEZ EM, Tanner AM, Du E, Patel SN, et al
    Decline in circulating viral and human tumor markers after resection of head and neck carcinoma.
    Head Neck. 2020 Aug 28. doi: 10.1002/hed.26444.
    >> Share

  185. SU L, Lin Q, Li R, Hua Y, et al
    Prognostic value of nutritional impairment on treatment-related toxicity and survival in patients with nasopharyngeal carcinoma taking normal nutrition before radiotherapy.
    Head Neck. 2020 Aug 27. doi: 10.1002/hed.26426.
    >> Share

  186. CRAWFORD KL, Jafari A, Qualliotine JR, Stuart E, et al
    Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinoma.
    Head Neck. 2020 Aug 24. doi: 10.1002/hed.26418.
    >> Share

  187. ZHI-JUN X, Yue-Xiao L, Bo-Yu G, Ya-Tin J, et al
    Are contralateral submental artery perforator flaps feasible for the reconstruction of postoperative defects of oral cancer?
    Head Neck. 2020 Aug 22. doi: 10.1002/hed.26422.
    >> Share

  188. DOUGLAS CM, Jethwa AR, Hasan W, Liu A, et al
    Long-term survival of head and neck squamous cell carcinoma after bone marrow transplant.
    Head Neck. 2020 Aug 21. doi: 10.1002/hed.26402.
    >> Share

  189. STANISZ I, Janik S, Grasl MC, Erovic BM, et al
    Panendoscopy during follow-up in laryngeal carcinoma patients after radiotherapy.
    Head Neck. 2020 Aug 21. doi: 10.1002/hed.26433.
    >> Share

  190. ARBAB M, Chen YH, Criscitiello S, Glass J, et al
    Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin.
    Head Neck. 2020 Aug 19. doi: 10.1002/hed.26432.
    >> Share

  191. NABUURS CH, Kievit W, Labbe N, Leemans CR, et al
    Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal.
    Head Neck. 2020 Aug 13. doi: 10.1002/hed.26424.
    >> Share

  192. MALIK A, Nair S
    Reply to Letter to the Editor regarding "Soft tissue deposits in oral cancers".
    Head Neck. 2020 Aug 13. doi: 10.1002/hed.26412.
    >> Share

  193. SMITH DK, Cmelak A, Niermann K, Ghiam M, et al
    Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation.
    Head Neck. 2020 Aug 7. doi: 10.1002/hed.26407.
    >> Share

  194. URABE M, Ueno M, Udagawa H
    Incidental identification of cervical nodal metastases from papillary thyroid carcinoma: Experiences related to esophageal cancer surgery.
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26392.
    >> Share

  195. SHAH J
    Reply to the Letter to the Editor regarding "Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens".
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26391.
    >> Share

  196. DU C, Tao Y
    Response to comments HN-20-1003 "Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma: useful treatment option with a caveat".
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26408.
    >> Share

  197. CHAKRABORTY A, Thiagarajan S
    Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma-Useful treatment option with a caveat.
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26413.
    >> Share

  198. KRAFT S, Gadkaree SK, Deschler DG, Lin DT, et al
    Programmed cell death ligand-1 and cytotoxic T cell infiltrates in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2020 Aug 1. doi: 10.1002/hed.26370.
    >> Share

    July 2020
  199. JEANS C, Brown B, Ward EC, Vertigan AE, et al
    Comparing the prevalence, location, and severity of head and neck lymphedema after postoperative radiotherapy for oral cavity cancers and definitive chemoradiotherapy for oropharyngeal, laryngeal, and hypopharyngeal cancers.
    Head Neck. 2020 Jul 31. doi: 10.1002/hed.26394.
    >> Share

  200. KARAN N, Siddiqui S, Sharma KS, Pantvaidya GH, et al
    Evaluation and validation of Physiological and Operative Severity Score for the enumeration of mortality and morbidity and Portsmouth-POSSUM scores in predicting morbidity and mortality in patients undergoing head and neck cancer surgeries.
    Head Neck. 2020 Jul 27. doi: 10.1002/hed.26354.
    >> Share

  201. GOGINENI E, Rana Z, Vempati P, Karten J, et al
    Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer.
    Head Neck. 2020 Jul 21. doi: 10.1002/hed.26342.
    >> Share

  202. DEUTSCH FT, Khoury SJ, Sunwoo JB, Elliott MS, et al
    Application of salivary noncoding microRNAs for the diagnosis of oral cancers.
    Head Neck. 2020 Jul 20. doi: 10.1002/hed.26348.
    >> Share

  203. LINDEGAARD AM, von Buchwald C, Rasmussen JH, Specht L, et al
    Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer.
    Head Neck. 2020 Jul 18. doi: 10.1002/hed.26361.
    >> Share

  204. UEKI Y, Takahashi T, Ota H, Shodo R, et al
    Role of programmed death-ligand 1 in predicting the treatment outcome of salvage chemotherapy after nivolumab in recurrent/metastatic head and neck squamous cell carcinoma.
    Head Neck. 2020 Jul 16. doi: 10.1002/hed.26374.
    >> Share

  205. DAGAN O, Moore A, Nachlon Y, Alkan U, et al
    Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience.
    Head Neck. 2020 Jul 16. doi: 10.1002/hed.26353.
    >> Share

  206. CAPUTO MP, Shabani S, Mhaskar R, McMullen C, et al
    Diabetes mellitus in major head and neck cancer surgery: Systematic review and meta-analysis.
    Head Neck. 2020 Jul 11. doi: 10.1002/hed.26349.
    >> Share

  207. LE ROUX MK, Graillon N, Guyot L, Taieb D, et al
    Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study.
    Head Neck. 2020 Jul 11. doi: 10.1002/hed.26359.
    >> Share

  208. TAE K, Kim KH
    Transoral robotic selective neck dissection for papillary thyroid carcinoma: Dissection of Levels III and IV.
    Head Neck. 2020 Jul 7. doi: 10.1002/hed.26379.
    >> Share

  209. HOLMES BJ, von Eyben R, Attardi LD, Kong CS, et al
    Pilot study of loss of the p53/p63 target gene PERP at the surgical margin as a potential predictor of local relapse in head and neck squamous cell carcinoma.
    Head Neck. 2020 Jul 7. doi: 10.1002/hed.26358.
    >> Share

  210. MUSORO JZ, Coens C, Singer S, Tribius S, et al
    Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.
    Head Neck. 2020 Jul 6. doi: 10.1002/hed.26363.
    >> Share

  211. FARQUHAR DR, Lenze NR, Masood MM, Divaris K, et al
    Access to preventive care services and stage at diagnosis in head and neck cancer.
    Head Neck. 2020 Jul 3. doi: 10.1002/hed.26326.
    >> Share

  212. LANDIN D, Ahrlund-Richter A, Mirzaie L, Mints M, et al
    Immune related proteins and tumor infiltrating CD8+ lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome.
    Head Neck. 2020 Jul 1. doi: 10.1002/hed.26364.
    >> Share

  213. KARLIGKIOTIS A, Arosio AD, Battaglia P, Sileo G, et al
    Changing paradigms in sinus and skull base surgery as the COVID-19 pandemic evolves: Preliminary experience from a single Italian tertiary care center.
    Head Neck. 2020;42:1610-1620.
    >> Share

  214. LAYFIELD E, Triantafillou V, Prasad A, Deng J, et al
    Telemedicine for head and neck ambulatory visits during COVID-19: Evaluating usability and patient satisfaction.
    Head Neck. 2020;42:1681-1689.
    >> Share

  215. TURRI-ZANONI M, Battaglia P, Karligkiotis A, Locatelli D, et al
    Managing care for patients with sinonasal and anterior skull base cancers during the COVID-19 pandemic.
    Head Neck. 2020;42:1503-1506.
    >> Share

    June 2020
  216. FERRANDINO RM, Roof S, Garneau J, Haidar Y, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck.
    Head Neck. 2020 Jun 27. doi: 10.1002/hed.26329.
    >> Share

  217. LEON X, Neumann E, Gutierrez A, Garcia J, et al
    Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV-negative head and neck squamous cell carcinoma patients.
    Head Neck. 2020 Jun 26. doi: 10.1002/hed.26340.
    >> Share

  218. WEINSTEIN GS, Cohen R, Lin A, O'Malley BW Jr, et al
    Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines.
    Head Neck. 2020 Jun 25. doi: 10.1002/hed.26318.
    >> Share

  219. YEN CJ, Kiyota N, Hanai N, Takahashi S, et al
    Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141).
    Head Neck. 2020 Jun 24. doi: 10.1002/hed.26331.
    >> Share

  220. HOLCOMB AJ, Perryman M, Goodwin S, Penn J, et al
    Pathology protocol increases lymph node yield in neck dissection for oral cavity squamous cell carcinoma.
    Head Neck. 2020 Jun 24. doi: 10.1002/hed.26343.
    >> Share

  221. GRABOYES E, Cramer J, Balakrishnan K, Cognetti DM, et al
    COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizon.
    Head Neck. 2020 Jun 20. doi: 10.1002/hed.26345.
    >> Share

  222. OH J, Liu A, Tran E, Berthelet E, et al
    Association between nutritional risk index and outcomes for head and neck cancer patients receiving concurrent chemo-radiotherapy.
    Head Neck. 2020 Jun 20. doi: 10.1002/hed.26315.
    >> Share

  223. VAN DER GEER SJ, van Rijn PV, Roodenburg JLN, Dijkstra PU, et al
    Prognostic factors associated with a restricted mouth opening (trismus) in patients with head and neck cancer: Systematic review.
    Head Neck. 2020 Jun 18. doi: 10.1002/hed.26327.
    >> Share

  224. ALTERIO D, Volpe S, Marvaso G, Turturici I, et al
    Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy.
    Head Neck. 2020 Jun 18. doi: 10.1002/hed.26319.
    >> Share


  225. Corrigendum to "Evaluation of oncologic outcomes in head and neck cancer patients > 80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment" [Head and Neck, 2019:41(12):4128-4135].
    Head Neck. 2020 Jun 17. doi: 10.1002/hed.26309.
    >> Share

  226. CHOI Y, Ahn KJ, Jang J, Shin NY, et al
    Prognostic value of computed tomography-based volumetric body composition analysis in patients with head and neck cancer: Feasibility study.
    Head Neck. 2020 Jun 16. doi: 10.1002/hed.26310.
    >> Share

  227. PANNU JS, Simpson MC, Donovan CL, Adjei Boakye E, et al
    Sociodemographic correlates of head and neck cancer survival among patients with metastatic disease.
    Head Neck. 2020 Jun 16. doi: 10.1002/hed.26284.
    >> Share

  228. HALL JA, Rusten M, Abughazaleh RD, Wuertz B, et al
    Effects of PPAR-gamma agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies.
    Head Neck. 2020 Jun 9. doi: 10.1002/hed.26286.
    >> Share

  229. KEJNER AE, Li H, Li EY, Porterfield JZ, et al
    Reply to Letter to the Editor regarding "Treatment modality and outcomes in larynx cancer patients: A sex-based evaluation".
    Head Neck. 2020 Jun 8. doi: 10.1002/hed.26156.
    >> Share

  230. HUANG GJ, Huang ZH
    Treatment modality and outcomes in larynx cancer patients.
    Head Neck. 2020 Jun 8. doi: 10.1002/hed.26157.
    >> Share

  231. YAN F, Byun YJ, Nguyen SA, Stalcup ST, et al
    Predictive value of computed tomography in identifying extranodal extension in human papillomavirus-positive versus human papillomavirus-negative head and neck cancer.
    Head Neck. 2020 Jun 2. doi: 10.1002/hed.26281.
    >> Share

  232. KAWASHITA Y, Morimoto S, Tashiro K, Soutome S, et al
    Risk factors associated with the development of aspiration pneumonia in patients receiving radiotherapy for head and neck cancer: retrospective study.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26314.
    >> Share

  233. FRIED J, Etter JL, Stenzel AE, Joseph JM, et al
    Physical inactivity and head and neck cancer mortality.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26283.
    >> Share

  234. DAY AT, Dahlstrom KR, Lee R, Karam-Hage M, et al
    Impact of a tobacco treatment program on abstinence and survival rates among current smokers with head and neck squamous cell carcinoma.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26268.
    >> Share

  235. GALLI J, Settimi S, Tricarico L, Almadori G, et al
    Clinical and surgical management of patients with head and neck cancer in a COVID-19 dedicated center in Italy.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26263.
    >> Share

    May 2020
  236. MROUEH R, Tanskanen T, Haapaniemi A, Salo T, et al
    Familial cancer risk in family members and spouses of patients with early-onset head and neck cancer.
    Head Neck. 2020 May 30. doi: 10.1002/hed.26282.
    >> Share

  237. YAN F, Rauscher E, Hollinger A, Caputo MA, et al
    The role of head and neck cancer advocacy organizations during the COVID-19 pandemic.
    Head Neck. 2020 May 29. doi: 10.1002/hed.26287.
    >> Share

  238. PEI S, Chen L, Yang Y, Zhu X, et al
    Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma through co-expression network analysis.
    Head Neck. 2020 May 27. doi: 10.1002/hed.26266.
    >> Share

  239. PAGEDAR NA, Kendell N, Christensen AJ, Thomsen TA, et al
    Head and neck cancer survivorship from the patient perspective.
    Head Neck. 2020 May 23. doi: 10.1002/hed.26265.
    >> Share

  240. FOKI E, Gangl K, Kranebitter V, Niederberger-Leppin V, et al
    Early effects of cigarette smoke extract on human oral keratinocytes and carcinogenesis in head and neck squamous cell carcinoma.
    Head Neck. 2020 May 21. doi: 10.1002/hed.26247.
    >> Share

  241. LEE J, Shin IS, Kim WC, Yoon WS, et al
    Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: Meta-analysis and systematic review.
    Head Neck. 2020 May 21. doi: 10.1002/hed.26264.
    >> Share

  242. NILSEN ML, Clump DA 2nd, Kubik M, Losego K, et al
    Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic.
    Head Neck. 2020 May 18. doi: 10.1002/hed.26256.
    >> Share

  243. VERMA N, Patel S, Osborn V, McBride S, et al
    Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma.
    Head Neck. 2020 May 16. doi: 10.1002/hed.26245.
    >> Share

  244. BOWMAN R, Crosby DL, Sharma A
    Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID-19.
    Head Neck. 2020 May 16. doi: 10.1002/hed.26260.
    >> Share

  245. QIN T, Koneva LA, Liu Y, Zhang Y, et al
    Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer.
    Head Neck. 2020 May 14. doi: 10.1002/hed.26244.
    >> Share

  246. CHANG CF, Ei-Sayed IH, George JR, Heaton CM, et al
    Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients.
    Head Neck. 2020 May 13. doi: 10.1002/hed.26249.
    >> Share

  247. PALERI V, Hardman J, Tikka T, Bradley P, et al
    Rapid implementation of an evidence-based remote triaging system for assessment of suspected head and neck cancer referrals and patients on follow up after treatment during the COVID-19 pandemic: A model for international collaboration.
    Head Neck. 2020 May 6. doi: 10.1002/hed.26219.
    >> Share

  248. KIM DH, Kim Y, Kim SW, Hwang SH, et al
    Use of narrowband imaging for the diagnosis and screening of laryngeal cancer: A systematic review and meta-analysis.
    Head Neck. 2020 May 4. doi: 10.1002/hed.26186.
    >> Share

  249. CIVANTOS FJ, Leibowitz JM, Arnold DJ, Stubbs VC, et al
    Ethical Surgical Triage of Head and Neck Cancer Patients during the COVID-19 Pandemic.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26229.
    >> Share

  250. GUPTA A, Arora V, Nair D, Agrawal N, et al
    Status and strategies for the management of head and neck cancer during COVID-19 pandemic: Indian Scenario.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26227.
    >> Share

  251. LEE AK, FRCSEd RHC, FRCSEd EHL, Cheng HK, et al
    Mitigation of Head and Neck Cancer Service Disruption During COVID-19 in Hong Kong Through Telehealth and Multi-institution Collaboration.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26226.
    >> Share

    April 2020
  252. MASSA ST, Pipkorn P, Jackson RS, Zevallos JP, et al
    Access to a regular medical provider among head and neck cancer survivors.
    Head Neck. 2020 Apr 30. doi: 10.1002/hed.26182.
    >> Share

  253. KU PK, Holsinger FC, Chan JY, Yeung ZC, et al
    Management of Dysphagia in The Head and Neck Cancer Patient during COVID-19 Pandemic: A Practical Strategy.
    Head Neck. 2020 Apr 29. doi: 10.1002/hed.26224.
    >> Share

  254. PRASAD A, Brewster R, Newman JG, Rajasekaran K, et al
    Optimizing your telemedicine visit during the COVID-19 pandemic: Practice guidelines for patients with head and neck cancer.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26197.
    >> Share

  255. SHARMA A, Crosby DL
    Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26216.
    >> Share

  256. SILVERMAN DA, Lin C, Tamaki A, Puram SV, et al
    Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26217.
    >> Share

  257. CHOW VLY, Chan JYW, Ho VWY, Lee GCC, et al
    Conservation of personal protective equipment for head and neck cancer surgery during COVID-19 pandemic.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26215.
    >> Share

  258. SINGH AG, Deodhar J, Chaturvedi P
    Navigating the impact of COVID-19 on palliative care for head and neck cancer.
    Head Neck. 2020 Apr 27. doi: 10.1002/hed.26211.
    >> Share

  259. YAN F, Nguyen SA
    Head and neck cancer: A high-risk population for COVID-19.
    Head Neck. 2020 Apr 27. doi: 10.1002/hed.26209.
    >> Share

  260. NOEL CW, Stephens RF, Su JS, Xu W, et al
    Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer.
    Head Neck. 2020 Apr 25. doi: 10.1002/hed.26181.
    >> Share

  261. BHATTACHARJEE A, Patil VM, Dikshit R, Prabhash K, et al
    Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.
    Head Neck. 2020 Apr 24. doi: 10.1002/hed.26196.
    >> Share

  262. SHUMAN AG, Campbell BH
    An Ethical Framework for Head and Neck Cancer Care Impacted by COVID-19.
    Head Neck. 2020 Apr 24. doi: 10.1002/hed.26193.
    >> Share

  263. WANG L, Cao J, Wang X, Lin E, et al
    Proton and photon radiosensitization effects of niraparib, a PARP-1/-2 inhibitor, on human head and neck cancer cells.
    Head Neck. 2020 Apr 23. doi: 10.1002/hed.26155.
    >> Share

  264. DAI LB, Yu Q, Zhou SH, Bao YY, et al
    Effect of combination of curcumin and GLUT-1 AS-ODN on radiosensitivity of laryngeal carcinoma through regulating autophagy.
    Head Neck. 2020 Apr 21. doi: 10.1002/hed.26180.
    >> Share

  265. KLIGERMAN MP, Vukkadala N, Tsang RKY, Sunwoo JB, et al
    Managing the Head and Neck Cancer Patient with Tracheostomy or Laryngectomy During the COVID-19 Pandemic.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26171.
    >> Share

  266. BOAKYE EA, Jenkins W, Sharma A
    Disproportionate impact of COVID-19 Pandemic on Head and Neck Cancer Survivors.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26170.
    >> Share

  267. CIVANTOS AM, Carey RM, Lichtenstein GR, Lukens JN, et al
    Care of Immunocompromised Patients with Head and Neck Cancer During the COVID-19 Pandemic: Two Challenging and Informative Clinical Cases.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26165.
    >> Share

  268. RASSEKH CH, Jenks CM, Ochroch EA, Douglas JE, et al
    Management of the difficult airway in the COVID-19 pandemic: Illustrative complex head and neck cancer scenario.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26175.
    >> Share

  269. LEE MY, Allen CT
    Mechanisms of resistance to T cell-based immunotherapy in head and neck cancer.
    Head Neck. 2020 Apr 10. doi: 10.1002/hed.26158.
    >> Share

    March 2020
  270. VENGALOOR THOMAS T, Packianathan S, Bhanat E, Albert A, et al
    Oligometastatic head and neck cancer: Comprehensive review.
    Head Neck. 2020 Mar 27. doi: 10.1002/hed.26144.
    >> Share

  271. FRANZ L, Tealdo G, Contro G, Bandolin L, et al
    Biological tumor markers (maspin, CD105, nm23-H1) and disease relapse in laryngeal cancer: cluster analysis.
    Head Neck. 2020 Mar 25. doi: 10.1002/hed.26152.
    >> Share

  272. PARK D, Kim HY, Kim HK, You JY, et al
    Institutional experience of 200 consecutive papillary thyroid carcinoma patients in transoral robotic thyroidectomy surgeries.
    Head Neck. 2020 Mar 25. doi: 10.1002/hed.26149.
    >> Share

  273. HE Y, Zhao Z, Wang Y, Chai J, et al
    Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis.
    Head Neck. 2020 Mar 23. doi: 10.1002/hed.26141.
    >> Share

  274. HUANG T, Su N, Zhang X, Ma S, et al
    Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases.
    Head Neck. 2020 Mar 10. doi: 10.1002/hed.26130.
    >> Share

  275. MEHRA R, Huang H, Seal B, Tse J, et al
    Real-world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno-oncology therapy.
    Head Neck. 2020 Mar 9. doi: 10.1002/hed.26126.
    >> Share

  276. PASALIC D, Betancourt-Cuellar SL, Taku N, Ludmir EB, et al
    Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.
    Head Neck. 2020 Mar 4. doi: 10.1002/hed.26117.
    >> Share

  277. JACOMINA LE, Jacinto JKM, Co LBA, Yu KKL, et al
    The Role of postoperative external beam radiotherapy for differentiated thyroid carcinoma: A Systematic review and meta-analysis.
    Head Neck. 2020 Mar 4. doi: 10.1002/hed.26133.
    >> Share

    February 2020
  278. TOWNES TG, Navuluri S, Pytynia KB, Gunn GB, et al
    Assessing patient-reported symptom burden of long-term head and neck cancer survivors at annual surveillance in survivorship clinic.
    Head Neck. 2020 Feb 29. doi: 10.1002/hed.26119.
    >> Share

  279. KARSTEN RT, van der Molen L, Hamming-Vrieze O, van Son RJJH, et al
    Long-term swallowing, trismus, and speech outcomes after combined chemoradiotherapy and preventive rehabilitation for head and neck cancer; 10-year plus update.
    Head Neck. 2020 Feb 29. doi: 10.1002/hed.26120.
    >> Share

  280. LOFHEDE H, Wertsen M, Havstam C
    Palatal augmentation prostheses in individuals treated for head and neck cancer: Effects on speech and oral transport.
    Head Neck. 2020 Feb 27. doi: 10.1002/hed.26124.
    >> Share

  281. THIBOUW F, Duvillard C, Thibouw D, Bertaut A, et al
    Evaluation of the quality of the information received during head and neck cancer announcement: Prospective two-center study.
    Head Neck. 2020 Feb 24. doi: 10.1002/hed.26109.
    >> Share

  282. WAN Y, Liu H, Zhang M, Huang Z, et al
    Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2020 Feb 12. doi: 10.1002/hed.26104.
    >> Share

  283. TEXAKALIDIS P, Giannopoulos S, Tsouknidas I, Song S, et al
    Prevalence of carotid stenosis following radiotherapy for head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2020 Feb 12. doi: 10.1002/hed.26102.
    >> Share

  284. MALIK A, Nair S, Singh A, Lamba K, et al
    Soft tissue deposit in neck dissection specimen carries a poor prognosis in oral cancer: A matched pair analysis.
    Head Neck. 2020 Feb 11. doi: 10.1002/hed.26103.
    >> Share

  285. BAO X, Liu F, Chen Q, Chen L, et al
    Propensity score analysis exploring the impact of smoking and drinking on the prognosis of patients with oral cancer.
    Head Neck. 2020 Feb 7. doi: 10.1002/hed.26099.
    >> Share

  286. AYLWARD A, Park J, Abdelaziz S, Hunt JP, et al
    Individualized prediction of late-onset dysphagia in head and neck cancer survivors.
    Head Neck. 2020 Feb 7. doi: 10.1002/hed.26039.
    >> Share

  287. TWU CW, Wang WY, Tsou HH, Liu YC, et al
    Effects of Epstein-Barr virus viral load and different treatment modality for stage III nasopharyngeal carcinoma.
    Head Neck. 2020 Feb 3. doi: 10.1002/hed.26096.
    >> Share

  288. ILAPAKRUTY B, Rao VUS
    Is tailored management better than salvage in laryngeal squamous cell carcinomas.
    Head Neck. 2020;42:357.
    >> Share

  289. MIMICA X, Hanson M, Cohen MA
    Reply to the letter of the editor: Is tailored management better than salvage in laryngeal squamous cell carcinomas?
    Head Neck. 2020;42:358-359.
    >> Share

    January 2020
  290. RATURI V, Hojo H, Bhatt MLB, Suhel M, et al
    Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation.
    Head Neck. 2020 Jan 30. doi: 10.1002/hed.26083.
    >> Share

  291. SWIECICKI PL, Li P, Bellile E, Stucken C, et al
    Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin.
    Head Neck. 2020 Jan 27. doi: 10.1002/hed.26085.
    >> Share

  292. LIU YP, Xie YL, Zou X, You R, et al
    Techniques of endoscopic nasopharyngectomy for localized stage I nasopharyngeal carcinoma.
    Head Neck. 2020 Jan 24. doi: 10.1002/hed.26090.
    >> Share

  293. SOLDERA EB, Ortigara GB, Bonzanini LIL, Schulz RE, et al
    Clinical and sociodemographic factors associated with oral health-related quality of life in survivors of head and neck cancer.
    Head Neck. 2020 Jan 21. doi: 10.1002/hed.26063.
    >> Share

  294. AHN D, Lee GJ, Sohn JH, Jeon JH, et al
    Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma.
    Head Neck. 2020 Jan 13. doi: 10.1002/hed.26075.
    >> Share

  295. COGNETTI DM, Villaflor VM, Fakhry C, Miller MC, et al
    Survivorship support in head and neck cancer: American Head and Neck Society survey.
    Head Neck. 2020 Jan 10. doi: 10.1002/hed.26066.
    >> Share

  296. ROMAN BR, Lohia S, Mitra N, Wang MB, et al
    Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer.
    Head Neck. 2020 Jan 10. doi: 10.1002/hed.26071.
    >> Share

  297. BAHL A, Bhatia K, Choudhary P, Singhla S, et al
    Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Indian tertiary care retrospective analysis.
    Head Neck. 2020 Jan 8. doi: 10.1002/hed.26070.
    >> Share

  298. CHEE J, Liu X, Eu D, Loh T, et al
    Defining a cohort of oligometastatic nasopharyngeal carcinoma patients with improved clinical outcomes.
    Head Neck. 2020 Jan 7. doi: 10.1002/hed.26061.
    >> Share

  299. WALL LR, Ward EC, Cartmill B, Hill AJ, et al
    Prophylactic swallowing therapy for patients with head and neck cancer: A three-arm randomized parallel-group trial.
    Head Neck. 2020 Jan 6. doi: 10.1002/hed.26060.
    >> Share

  300. KOUDOUGOU C, Bertin H, Lecaplain B, Badran Z, et al
    Postimplantation radiation therapy in head and neck cancer patients: Literature review.
    Head Neck. 2020 Jan 3. doi: 10.1002/hed.26065.
    >> Share

  301. SULLIVAN CB, Al-Qurayshi Z, Pagedar NA
    Analysis of patients who decline treatment for squamous cell carcinoma of the head and neck: National perspective.
    Head Neck. 2020 Jan 2. doi: 10.1002/hed.26040.
    >> Share

  302. ILMARINEN T, Keski-Santti HT, Markkanen-Leppanen ML, Haapaniemi A, et al
    Reply to "Do not de-escalate oncology care in oropharyngeal cancer routinely".
    Head Neck. 2020;42:145-146.
    >> Share

  303. SZTURZ P, Vermorken JB
    Do not de-escalate oncology care in oropharyngeal cancer routinely.
    Head Neck. 2020;42:143-144.
    >> Share

    December 2019
  304. LEE YH, Goo-Yoshino S, Lew HL, Chi WC, et al
    Social participation in head and neck cancer survivors with swallowing disorder: World Health Organization Disability Assessment Schedule 2.0 study.
    Head Neck. 2019 Dec 30. doi: 10.1002/hed.26062.
    >> Share

  305. CHEN Q, Zou X, Ma Y, Liu F, et al
    Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection therapy for the treatment of chyle fistula following neck dissection.
    Head Neck. 2019 Dec 28. doi: 10.1002/hed.26054.
    >> Share

  306. MEHDIZADEH OB, Dhar SI, Evangelista L, Nativ-Zeltzer N, et al
    Prevalence of profound laryngeal sensory neuropathy in head and neck cancer survivors with feeding tube-dependent oropharyngeal dysphagia.
    Head Neck. 2019 Dec 27. doi: 10.1002/hed.26059.
    >> Share

  307. SUN C, Wang Q, Guo Q, Chang Q, et al
    Analysis of patterns and risk factors regarding the onset of nodules in the contralateral thyroid lobe during follow-up ultrasonography among patients after unilateral lobectomy for the treatment of papillary thyroid carcinoma.
    Head Neck. 2019 Dec 24. doi: 10.1002/hed.26056.
    >> Share

  308. RUEGG P, Morand GB, Kudura K, Rupp NJ, et al
    Tumor cell viability in salvage neck dissections: Poor prognosis predicted by high postradiation nodal SUVmax , p16-negativity, and low nodal shrinkage.
    Head Neck. 2019 Dec 19. doi: 10.1002/hed.26045.
    >> Share

  309. MAKITIE AA, Almangush A, Youssef O, Metsala M, et al
    Exhaled breath analysis in the diagnosis of head and neck cancer.
    Head Neck. 2019 Dec 19. doi: 10.1002/hed.26043.
    >> Share

  310. SAITO Y, Favorov AV, Forman M, Ren S, et al
    Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.
    Head Neck. 2019 Dec 18. doi: 10.1002/hed.26041.
    >> Share

  311. TIAN S, Switchenko JM, Fei T, Press RH, et al
    Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups.
    Head Neck. 2019 Dec 16. doi: 10.1002/hed.26042.
    >> Share

  312. YANG TH, Xirasagar S, Cheng YF, Wu CS, et al
    Association between pioglitazone use and head and neck cancer: Population-based case-control study.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26046.
    >> Share

  313. NAGHAVI AO, Kim Y, Yang GQ, Ahmed KA, et al
    Alterations in genetic pathways following radiotherapy for head and neck cancer.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26004.
    >> Share

  314. ROGERS SN, Alvear A, Anesi A, Babin E, et al
    Variations in concerns reported on the patient concerns inventory in patients with head and neck cancer from different health settings across the world.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26027.
    >> Share

  315. DU C, Blanchard P, Even C, Boros A, et al
    Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma.
    Head Neck. 2019 Dec 4. doi: 10.1002/hed.26021.
    >> Share

    November 2019
  316. WONG ECY, Hung JLC, Ng WT
    Potential pitfalls in incorporating plasma Epstein-Barr virus DNA in the management of nasopharyngeal carcinoma.
    Head Neck. 2019 Nov 28. doi: 10.1002/hed.26018.
    >> Share

  317. MARZILIANO A, Teckie S, Diefenbach MA
    Alcohol-related head and neck cancer: Summary of the literature.
    Head Neck. 2019 Nov 27. doi: 10.1002/hed.26023.
    >> Share

  318. PATEL JJ, Levy DA, Nguyen SA, Knochelmann HM, et al
    Impact of PD-L1 expression and human papillomavirus status in anti-PD1/PDL1 immunotherapy for head and neck squamous cell carcinoma-Systematic review and meta-analysis.
    Head Neck. 2019 Nov 24. doi: 10.1002/hed.26036.
    >> Share

  319. STEPHENS RF, Noel CW, Su JS, Xu W, et al
    Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer.
    Head Neck. 2019 Nov 24. doi: 10.1002/hed.26031.
    >> Share

  320. AGHAJANZADEH S, Karlsson T, Tuomi L, Finizia C, et al
    The effect of jaw exercises on anxiety and depression in patients with head and neck cancer receiving radiotherapy: Prospective 2-year follow-up study.
    Head Neck. 2019 Nov 22. doi: 10.1002/hed.26012.
    >> Share

  321. COCA-PELAZ A, Rodrigo JP, Suarez C, Nixon IJ, et al
    The risk of second primary tumors in head and neck cancer: A systematic review.
    Head Neck. 2019 Nov 21. doi: 10.1002/hed.26016.
    >> Share

  322. VALERO C, Pardo L, Sansa A, Garcia Lorenzo J, et al
    Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma.
    Head Neck. 2019 Nov 21. doi: 10.1002/hed.26010.
    >> Share

  323. PODEUR F, Pommier P, Crozes C, Monchet E, et al
    Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes.
    Head Neck. 2019 Nov 18. doi: 10.1002/hed.26007.
    >> Share

  324. NEVES-SILVA R, Almeida LY, Silveira HA, Colturato CBN, et al
    SMARCB1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
    Head Neck. 2019 Nov 15. doi: 10.1002/hed.26008.
    >> Share

  325. ZHANG Y, Xu S, Liu W, Wang X, et al
    Rational choice of neck dissection in clinically N0 patients with supraglottic cancer.
    Head Neck. 2019 Nov 14. doi: 10.1002/hed.26014.
    >> Share

  326. WANG L, Yang L, Han S, Zhu J, et al
    Patterns of protein expression in human head and neck cancer cell lines differ after proton vs photon radiotherapy.
    Head Neck. 2019 Nov 11. doi: 10.1002/hed.26005.
    >> Share

  327. BONOMO P, Talamonti C, Desideri I, Marrazzo L, et al
    Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy.
    Head Neck. 2019 Nov 4. doi: 10.1002/hed.25997.
    >> Share

  328. HURTADO-LOPEZ LM, Basurto-Kuba E
    In response: Tailored approach for recurrent laryngeal nerve dissection according to different endoscopic endocrine surgery.
    Head Neck. 2019;41:4062-4063.
    >> Share

  329. MICCOLI P, Dionigi G
    Tailored approach for recurrent laryngeal nerve dissection according to different endoscopic endocrine surgery.
    Head Neck. 2019;41:4060-4061.
    >> Share

    October 2019
  330. WILSON TG, Hanna A, Recknagel J, Pruetz BL, et al
    Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation.
    Head Neck. 2019 Oct 27. doi: 10.1002/hed.25983.
    >> Share

  331. HORI Y, Kubota A, Yokose T, Furukawa M, et al
    Association between pathological invasion patterns and late lymph node metastases in patients with surgically treated clinical No early oral tongue carcinoma.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25994.
    >> Share

  332. JANTHARAPATTANA K, Orapipatpong O
    Efficacy of EPA-enriched supplement compared with standard formula on body weight changes in malnourished patients with head and neck cancer undergone surgery: a randomized study.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25987.
    >> Share

  333. GOU X, Duan B, Shi H, Qin L, et al
    The relations of dosimetric parameters with long-term outcomes and late toxicities in advanced T-stage nasopharyngeal carcinoma with IMRT.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25986.
    >> Share

  334. PAIAR F, Cristaudo A, Gonnelli A, Giannini N, et al
    Radiation-induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? "A narrative review".
    Head Neck. 2019 Oct 21. doi: 10.1002/hed.25982.
    >> Share

  335. NG WT, Lee MC, Fung NT, Wong EC, et al
    Dose volume effects of re-irradiation for locally recurrent nasopharyngeal carcinoma.
    Head Neck. 2019 Oct 16. doi: 10.1002/hed.25988.
    >> Share

  336. DOOLEY BJ, Karassawa Zanoni D, Mcgill MR, Awad MI, et al
    Intraoperative and postanesthesia care unit fluid administration as risk factors for postoperative complications in patients with head and neck cancer undergoing free tissue transfer.
    Head Neck. 2019 Oct 8. doi: 10.1002/hed.25970.
    >> Share

  337. PARK H, Harries V, McGill MR, Ganly I, et al
    Isthmusectomy in selected patients with well-differentiated thyroid carcinoma.
    Head Neck. 2019 Oct 7. doi: 10.1002/hed.25968.
    >> Share

  338. AMINI A, Verma V, Li R, Vora N, et al
    Factors predicting for patient refusal of head and neck cancer therapy.
    Head Neck. 2019 Oct 4. doi: 10.1002/hed.25966.
    >> Share

  339. KAO HF, Lou PJ
    Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions.
    Head Neck. 2019;41 Suppl 1:4-18.
    >> Share

  340. LOU PJ
    Preface for the special issue of "Immunotherapy for head and neck cancers: Current landscapes, emerging biomarkers, and future directions".
    Head Neck. 2019;41 Suppl 1:3.
    >> Share

  341. CHEN TH, Chang PM, Yang MH
    Novel immune-modulating drugs for advanced head and neck cancer.
    Head Neck. 2019;41 Suppl 1:46-56.
    >> Share

  342. HSIEH JC, Wang HM, Wu MH, Chang KP, et al
    Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy.
    Head Neck. 2019;41 Suppl 1:19-45.
    >> Share

  343. NISHIO N, van Keulen S, van den Berg NS, Lu G, et al
    Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment.
    Head Neck. 2019 Oct 1. doi: 10.1002/hed.25964.
    >> Share

  344. ORLANDI E, Iacovelli NA, Cavallo A, Resteghini C, et al
    Could the extreme conformality achieved with proton therapy in paranasal sinuses cancers accidentally results in a high rate of leptomeningeal progression?
    Head Neck. 2019;41:3733-3735.
    >> Share

    September 2019
  345. BALAGUER M, Pommee T, Farinas J, Pinquier J, et al
    Effects of oral and oropharyngeal cancer on speech intelligibility using acoustic analysis: Systematic review.
    Head Neck. 2019 Sep 30. doi: 10.1002/hed.25949.
    >> Share

  346. HAN JE, Yi SK, Wang S, Erman A, et al
    Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.
    Head Neck. 2019 Sep 14. doi: 10.1002/hed.25955.
    >> Share

  347. WU L, Zhuo S, Zeng W, Liang S, et al
    Paranasal sinus invasion suggested T4 classification of patients of nasopharyngeal carcinoma: A two-center retrospective investigation.
    Head Neck. 2019 Sep 13. doi: 10.1002/hed.25953.
    >> Share

  348. RODEN D, Daniels K, Metkus J, Goldman R, et al
    Evaluation of oncologic outcomes in head and neck cancer patients >/=80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25950.
    >> Share

  349. MOWERY AJ, Conlin MJ, Clayburgh DR
    Elevated incidence of head and neck cancer in solid organ transplant recipients.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25937.
    >> Share

  350. GIRKAR F, Thiagarajan S, Malik A, Sawhney S, et al
    Factors predisposing to the development of orocutaneous fistula following surgery for oral cancer: Experience from a tertiary cancer center.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25951.
    >> Share

  351. TAM S, Nurgalieva Z, Weber RS, Lewis CM, et al
    Adherence with National Comprehensive Cancer Network posttreatment surveillance guidelines in patients with head and neck cancer.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25936.
    >> Share

  352. BRISSON RJ, Kochanny S, Arshad S, Dekker A, et al
    A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Sep 4. doi: 10.1002/hed.25910.
    >> Share

  353. MASKELL D, Buckley H, Sisson K, Roques T, et al
    In reply to McDowell et al.
    Head Neck. 2019;41:3470-3471.
    >> Share

  354. MCDOWELL L, Corry J
    Comment on "Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer-Approach with caution".
    Head Neck. 2019;41:3468-3469.
    >> Share

    August 2019
  355. KARSTEN RT, Al-Mamgani A, Bril SI, Tjon-A-Joe S, et al
    Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer.
    Head Neck. 2019 Aug 31. doi: 10.1002/hed.25938.
    >> Share

  356. XU SY, Yao JJ, Zhou W, Chen L, et al
    Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion.
    Head Neck. 2019 Aug 29. doi: 10.1002/hed.25941.
    >> Share

  357. ELDRIDGE RC, Pugh SL, Trotti A, Hu K, et al
    Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25922.
    >> Share

  358. CHEN JH, Huang WY, Ho CL, Chao TY, et al
    Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinoma.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25904.
    >> Share

  359. MIMICA X, Hanson M, Patel SG, McGill M, et al
    Salvage surgery for recurrent larynx cancer.
    Head Neck. 2019 Aug 21. doi: 10.1002/hed.25925.
    >> Share

  360. CHO Y, Yoon HI, Lee IJ, Kim JW, et al
    Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes.
    Head Neck. 2019 Aug 20. doi: 10.1002/hed.25928.
    >> Share

  361. TAN AL, Iyer NG, Putri N, Nadkarni N, et al
    Factors driving frequent attendance at emergency departments for patients with head and neck cancer.
    Head Neck. 2019 Aug 18. doi: 10.1002/hed.25916.
    >> Share

  362. SHAH M, Jomaa MK, Ferrarotto R, Yeung SJ, et al
    Serious immune-related adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review.
    Head Neck. 2019 Aug 15. doi: 10.1002/hed.25911.
    >> Share

  363. GILL AS, Kinzinger M, Bewley AF, Farwell DG, et al
    Malnutrition evaluation in head and neck cancer patients: Practice patterns among otolaryngologists and radiation oncologists.
    Head Neck. 2019 Aug 12. doi: 10.1002/hed.25909.
    >> Share

  364. LIN DJ, Lam A, Warner L, Paleri V, et al
    Elective neck dissection in patients with radio-recurrent and radio-residual squamous cell carcinoma of the larynx undergoing salvage total laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2019 Aug 10. doi: 10.1002/hed.25907.
    >> Share

  365. ALMADORI G, De Corso E, Visconti G, Almadori A, et al
    Impact of internal mammary artery perforator propeller flap in neck resurfacing and fistula closure after salvage larynx cancer surgery: Our experience.
    Head Neck. 2019 Aug 9. doi: 10.1002/hed.25903.
    >> Share

  366. LI H, Li EY, Kejner AE
    Treatment modality and outcomes in larynx cancer patients: A sex-based evaluation.
    Head Neck. 2019 Aug 7. doi: 10.1002/hed.25897.
    >> Share

  367. MANDAPATHIL M, Lennon P, Ganly I, Patel SG, et al
    Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens.
    Head Neck. 2019 Aug 7. doi: 10.1002/hed.25905.
    >> Share

  368. MASCARELLA MA, Azzi JL, da Silva SD, Mlynarek A, et al
    Postoperative infection predicts poor survival in locoregionally advanced oral cancer.
    Head Neck. 2019 Aug 5. doi: 10.1002/hed.25885.
    >> Share

  369. MCGURK M
    Surgical consensus guidelines on sentinel node biopsy in patients with oral cancer.
    Head Neck. 2019 Aug 5. doi: 10.1002/hed.25898.
    >> Share

  370. KWAN BYM, Khan NM, de Almeida JR, Goldstein D, et al
    Transoral robotic surgery for head and neck malignancies: Imaging features in presurgical workup.
    Head Neck. 2019 Aug 1. doi: 10.1002/hed.25887.
    >> Share

    July 2019
  371. JAKOB M, Mattes LM, Kuffer S, Unger K, et al
    MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25866.
    >> Share

  372. ORLANDI E, Bonomo P, Ferella L, D'Angelo E, et al
    Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25890.
    >> Share

  373. LE GUEVELOU J, Lebars S, Kammerer E, de Gabory L, et al
    Head and neck cancer during pregnancy.
    Head Neck. 2019 Jul 22. doi: 10.1002/hed.25877.
    >> Share

  374. MAKITIE AA, Almangush A, Rodrigo JP, Ferlito A, et al
    Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer.
    Head Neck. 2019 Jul 22. doi: 10.1002/hed.25872.
    >> Share

  375. LU T, Xie X, Guo Q, Zhan S, et al
    Prognosis of nasopharyngeal carcinoma with insufficient radical dose to the primary site in the intensity-modulated radiotherapy era.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25865.
    >> Share

  376. PAULI N, Mejersjo C, Fagerberg-Mohlin B, Finizia C, et al
    Temporomandibular disorder in head and neck cancer patients undergoing radiotherapy: Clinical findings and patient-reported symptoms.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25878.
    >> Share

  377. MARIONI G, Nicole L, Cazzador D, Pavone C, et al
    Endoglin (CD105) expression in neurofibromatosis type 2 vestibular schwannoma.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25881.
    >> Share

  378. RASSY E, Nicolai P, Pavlidis N
    Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary.
    Head Neck. 2019 Jul 13. doi: 10.1002/hed.25858.
    >> Share

  379. LI X, Zhou J, Chu C, You Q, et al
    Home enteral nutrition may prevent myelosuppression of patients with nasopharyngeal carcinoma treated by concurrent chemoradiotherapy.
    Head Neck. 2019 Jul 12. doi: 10.1002/hed.25861.
    >> Share

  380. PETRUZZI G, Zocchi J, Moretto S, Pichi B, et al
    Transoral robotic retropharyngeal lymph node dissection in a recurrent head and neck carcinoma.
    Head Neck. 2019 Jul 11. doi: 10.1002/hed.25874.
    >> Share

  381. ABOUYARED M, Katz AP, Ein L, Ketner J, et al
    Controversies in free tissue transfer for head and neck cancer: A review of the literature.
    Head Neck. 2019 Jul 9. doi: 10.1002/hed.25853.
    >> Share

  382. KIM SH, Lee WH, Seong D, An JH, et al
    The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation.
    Head Neck. 2019 Jul 3. doi: 10.1002/hed.25868.
    >> Share

  383. SU Z, Cao X, Zou G
    Brain and frontal-bone metastasis from nasopharyngeal carcinoma: Case report and literature review.
    Head Neck. 2019 Jul 2. doi: 10.1002/hed.25859.
    >> Share

    June 2019
  384. WANG JR, Nurgalieva Z, Fu S, Tam S, et al
    Utilization of rehabilitation services in patients with head and neck cancer in the United States: A SEER-Medicare analysis.
    Head Neck. 2019 Jun 25. doi: 10.1002/hed.25844.
    >> Share

  385. MOORE P, Grinsell D, Lyons B, Hewson I, et al
    Outcomes of dental and craniofacial osseointegrated implantation in head and neck cancer patients.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25845.
    >> Share

  386. WATTERS AL, Cope S, Keller MN, Padilla M, et al
    Prevalence of trismus in patients with head and neck cancer: A systematic review with meta-analysis.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25836.
    >> Share

  387. OH J, Prisman E, Olson R, Berthelet E, et al
    Primary organ preservation vs total laryngectomy for T4a larynx cancer.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25838.
    >> Share

  388. HU Y, Lu T, Huang SH, Lin S, et al
    High-grade radiologic extra-nodal extension predicts distant metastasis in stage II nasopharyngeal carcinoma.
    Head Neck. 2019 Jun 17. doi: 10.1002/hed.25842.
    >> Share

  389. WANG KY, Yang KC, Su FY, Chen YC, et al
    Association between blood pressure and postoperative hematomas in the patients undergoing head and neck cancer reconstruction.
    Head Neck. 2019 Jun 7. doi: 10.1002/hed.25831.
    >> Share

  390. MIROSEVIC S, Thewes B, van Herpen C, Kaanders J, et al
    Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer.
    Head Neck. 2019 Jun 7. doi: 10.1002/hed.25812.
    >> Share

  391. POWROZEK T, Brzozowska A, Mazurek M, Mlak R, et al
    Combined analysis of miRNA-181a with phase angle derived from bioelectrical impedance predicts radiotherapy-induced changes in body composition and survival of male patients with head and neck cancer.
    Head Neck. 2019 Jun 4. doi: 10.1002/hed.25830.
    >> Share

  392. VUONG HG, Ho ATN, Tran TTK, Capdevila J, et al
    Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2019 Jun 4. doi: 10.1002/hed.25832.
    >> Share

    May 2019
  393. CHEN JL, Shen CW, Wang CC, Huang YS, et al
    Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective study.
    Head Neck. 2019 May 22. doi: 10.1002/hed.25814.
    >> Share

  394. DELAHAUT G, Temam S, Ambroise J, Tao Y, et al
    Prognostic impact of tumor growth velocity in head and neck squamous cell carcinoma treated by radiotherapy: A pilot study.
    Head Neck. 2019 May 14. doi: 10.1002/hed.25789.
    >> Share

  395. JACOBI C, Gahleitner C, Bier H, Knopf A, et al
    Chemoradiation and local recurrence of head and neck squamous cell carcinoma and the risk of carotid artery blowout.
    Head Neck. 2019 May 9. doi: 10.1002/hed.25796.
    >> Share

    April 2019
  396. DANIELS KE, Luginbuhl AJ, Mardekian SK, Cognetti DM, et al
    Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma.
    Head Neck. 2019 Apr 29. doi: 10.1002/hed.25794.
    >> Share

  397. VAN DE GOOR RMGE, Hardy JCA, van Hooren MRA, Kremer B, et al
    Detecting recurrent head and neck cancer using electronic nose technology: A feasibility study.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25787.
    >> Share

  398. HO YY, Wu TY, Cheng HC, Yang CC, et al
    The significance of tumor budding in oral cancer survival and its relevance to the eighth edition of the American Joint Committee on Cancer staging system.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25780.
    >> Share

  399. THAM T, Machado R, Herman SW, Kraus D, et al
    Personalized prognostication in head and neck cancer: A systematic review of nomograms according to the AJCC precision medicine core (PMC) criteria.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25778.
    >> Share

  400. SONG YC, Hung KF, Liang KL, Chiang JH, et al
    Adjunctive Chinese herbal medicine therapy for nasopharyngeal carcinoma: Clinical evidence and experimental validation.
    Head Neck. 2019 Apr 15. doi: 10.1002/hed.25766.
    >> Share

  401. DURAN G, Aguin S, Cruz R, Barros F, et al
    Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment.
    Head Neck. 2019 Apr 11. doi: 10.1002/hed.25754.
    >> Share

  402. DE KORT WWB, Maas SLN, Van Es RJJ, Willems SM, et al
    Prognostic value of the nodal yield in head and neck squamous cell carcinoma: A systematic review.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25764.
    >> Share

  403. MIYAGAWA Y, Araki K, Yamashita T, Tanaka S, et al
    Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase-specific oncolytic Sendai virus.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25769.
    >> Share

  404. CHEN F, Yan L, Wang J, Lin L, et al
    Upregulated long noncoding RNA ENST00000470447.1 inhibits cell migration and invasion and predicts better disease-free survival of oral cancer.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25765.
    >> Share

  405. PANDA S, Thakar A, Sikka K, Sharma SC, et al
    Role of sternomastoid muscle interposition in concomitant transoral oncologic resection and neck dissection.
    Head Neck. 2019 Apr 4. doi: 10.1002/hed.25753.
    >> Share

    March 2019
  406. YOUNG LK, Vimawala S, Ahmad N, Kushnir V, et al
    Review of inbound medical tourism and legal details of obtaining a visa for treatment of head and neck cancer.
    Head Neck. 2019 Mar 25. doi: 10.1002/hed.25743.
    >> Share

  407. COSTA EFD, Lopes-Aguiar L, Nogueira GS, Lima TRP, et al
    CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 23. doi: 10.1002/hed.25746.
    >> Share

  408. WANG HM, Wu MH, Chang PH, Lin HC, et al
    The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer.
    Head Neck. 2019 Mar 22. doi: 10.1002/hed.25744.
    >> Share

  409. MEANS C, Clayburgh DR, Maloney L, Sauer D, et al
    Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25740.
    >> Share

  410. SCHILLING C, Stoeckli SJ, Vigili MG, de Bree R, et al
    Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25739.
    >> Share

  411. KIM H, Shin JH, Hahn SY, Oh YL, et al
    Prediction of follicular thyroid carcinoma associated with distant metastasis in the preoperative and postoperative model.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25721.
    >> Share

  412. HENRY M, Fuehrmann F, Hier M, Zeitouni A, et al
    Contextual and historical factors for increased levels of anxiety and depression in patients with head and neck cancer: A prospective longitudinal study.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25725.
    >> Share

  413. MORSE RT, Ganju RG, TenNapel MJ, Neupane P, et al
    Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 11. doi: 10.1002/hed.25717.
    >> Share

  414. JANG JY, Kim DS, Park HY, Shin SC, et al
    Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma.
    Head Neck. 2019 Mar 7. doi: 10.1002/hed.25729.
    >> Share

  415. BAI S, Zhang P, Zhang JC, Shen J, et al
    A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 6. doi: 10.1002/hed.25731.
    >> Share

  416. YASUMATSU R, Wakasaki T, Hashimoto K, Nakashima K, et al
    Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25737.
    >> Share

  417. MOHAMED A, Twardy B, Zordok MA, Ashraf K, et al
    Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: A comparative analysis.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25379.
    >> Share

  418. NAKANO K, Seto A, Sasaki T, Shimbashi W, et al
    Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25727.
    >> Share

  419. FADEN DL, Concha-Benavente F, Chakka AB, McMichael EL, et al
    Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25726.
    >> Share

  420. MAEBAYASHI T, Ishibashi N, Aizawa T, Sakaguchi M, et al
    Effectiveness of chemoradiotherapy for radiation-induced bilateral external auditory canal cancer: A case report and literature review.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25728.
    >> Share

  421. VAN SCHAIK JE, Muller Kobold AC, van der Laan BFAM, van der Vegt B, et al
    Squamous cell carcinoma antigen concentration in fine needle aspiration samples: A new method to detect cervical lymph node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25733.
    >> Share

  422. MORATIN J, Metzger K, Safaltin A, Herpel E, et al
    Upregulation of PD-L1 and PD-L2 in neck node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 1. doi: 10.1002/hed.25713.
    >> Share

    February 2019
  423. TU HF, Chen MY, Lai JC, Chen YL, et al
    Arecoline-regulated ataxia telangiectasia mutated expression level in oral cancer progression.
    Head Neck. 2019 Feb 28. doi: 10.1002/hed.25718.
    >> Share

  424. MIRZA AH, Thomas G, Ottensmeier CH, King EV, et al
    Importance of the immune system in head and neck cancer.
    Head Neck. 2019 Feb 28. doi: 10.1002/hed.25716.
    >> Share

  425. KAO LT, Hung SH, Kao PF, Liu JC, et al
    Inverse association between statin use and head and neck cancer: A population-based case-control study in Han population.
    Head Neck. 2019 Feb 26. doi: 10.1002/hed.25501.
    >> Share

  426. RODRIGUES-JUNIOR DM, Tan SS, Lim SK, de Souza Viana L, et al
    High expression of MLANA in the plasma of patients with head and neck squamous cell carcinoma as a predictor of tumor progression.
    Head Neck. 2019 Feb 25. doi: 10.1002/hed.25510.
    >> Share

  427. ROBBINS KT, Medina J, Ferlito A
    Adding clarity to the historical evolution of the selective neck dissection.
    Head Neck. 2019 Feb 23. doi: 10.1002/hed.25704.
    >> Share

  428. STELZLE F, Oetter N, Goellner LT, Adler W, et al
    Speech intelligibility in patients with oral cancer: An objective baseline evaluation of pretreatment function and impairment.
    Head Neck. 2019 Feb 23. doi: 10.1002/hed.25527.
    >> Share

  429. SMEE R, Williams JR, Kotevski DP
    Surgery is not the only determinant of an outcome in patients with hypopharyngeal carcinoma.
    Head Neck. 2019 Feb 21. doi: 10.1002/hed.25496.
    >> Share

  430. BATES JE, De Leo AN, Morris CG, Amdur RJ, et al
    Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes.
    Head Neck. 2019 Feb 20. doi: 10.1002/hed.25695.
    >> Share

  431. WALD P, Grecula J, Walston S, Wei L, et al
    Intraoperative electron beam radiotherapy for locoregionally persistent or recurrent head and neck cancer.
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25673.
    >> Share

  432. TASSLER AB, Gooding WE, Ferris RL
    Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit?
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25687.
    >> Share

  433. SHAHA AR
    Recent historic perspective on modified neck dissection.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25700.
    >> Share

  434. WANG B, Weng YJ, Wang SS, Zhao WX, et al
    Feasibility and safety of needle-assisted endoscopic thyroidectomy with lateral neck dissection for papillary thyroid carcinoma: a preliminary experience.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25705.
    >> Share

  435. KHARIWALA SS, Rubin N, Stepanov I, Nollen N, et al
    "Cold turkey" or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer.
    Head Neck. 2019 Feb 15. doi: 10.1002/hed.25708.
    >> Share

  436. VAN DEN STEEN L, Van Gestel D, Vanderveken O, Vanderwegen J, et al
    Evolution of self-perceived swallowing function, tongue strength and swallow-related quality of life during radiotherapy in head and neck cancer patients.
    Head Neck. 2019 Feb 14. doi: 10.1002/hed.25684.
    >> Share

  437. KIM HK, Park D, Kim HY
    Robotic transoral thyroidectomy: Total thyroidectomy and ipsilateral central neck dissection with da Vinci Xi Surgical System.
    Head Neck. 2019 Feb 13. doi: 10.1002/hed.25661.
    >> Share

  438. COCA-PELAZ A, Halmos GB, Strojan P, de Bree R, et al
    The role of age in treatment-related adverse events in patients with head and neck cancer: A systematic review.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25696.
    >> Share

  439. SUN W, Chen L, Huang JQ, Li J, et al
    Dynamic changes in chemosensitivity immune predictors in patients with hypopharyngeal cancer treated with induction chemotherapy.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25699.
    >> Share

  440. AVKSHTOL V, Handorf EA, Ridge JA, Leachman BK, et al
    Examining adjuvant radiation dose in head and neck squamous cell carcinoma.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25680.
    >> Share

  441. LIU J, Lu D, Deng D, Wang J, et al
    Free posterior tibial artery perforator flap for 2-stage tracheal reconstruction in patients after resection of well-differentiated thyroid carcinoma invading the trachea.
    Head Neck. 2019 Feb 6. doi: 10.1002/hed.25675.
    >> Share

  442. HUTCHISON AR, Cartmill B, Wall LR, Ward EC, et al
    Dysphagia optimized radiotherapy to reduce swallowing dysfunction severity in patients undergoing treatment for head and neck cancer: A systematized scoping review.
    Head Neck. 2019 Feb 5. doi: 10.1002/hed.25688.
    >> Share

  443. MUELLER SA, Riggauer J, Elicin O, Blaser D, et al
    Patients' preferences concerning follow-up after curative head and neck cancer treatment: A cross-sectional pilot study.
    Head Neck. 2019 Feb 5. doi: 10.1002/hed.25686.
    >> Share

  444. LI L, Sun Z, Huang X, Li X, et al
    Role of c-Met expression on prognosis of head and neck cancer: A literature review and meta-analysis.
    Head Neck. 2019 Feb 1. doi: 10.1002/hed.25655.
    >> Share

    January 2019
  445. STRIETH S, Ernst BP, Both I, Hirth D, et al
    Randomized controlled single-blinded clinical trial of functional voice outcome after vascular targeting KTP laser microsurgery of early laryngeal cancer.
    Head Neck. 2019 Jan 31. doi: 10.1002/hed.25474.
    >> Share

  446. BUSSU F, Tagliaferri L, Mattiucci G, Parrilla C, et al
    HDR interventional radiotherapy (brachytherapy) in the treatment of primary and recurrent head and neck malignancies.
    Head Neck. 2019 Jan 30. doi: 10.1002/hed.25646.
    >> Share

  447. LANG S, Schimansky S, Beynon R, Penfold C, et al
    Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000.
    Head Neck. 2019 Jan 30. doi: 10.1002/hed.25660.
    >> Share

  448. ARBAB M, Margalit DN, Tishler RB, Rabinowits G, et al
    Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence.
    Head Neck. 2019 Jan 29. doi: 10.1002/hed.25663.
    >> Share

  449. SWEGAL WC, Iwata AJ, Chang SS
    Developing a patient driven head and neck cancer care pathway.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25590.
    >> Share

  450. MENDEZ LC, Conrad T, Lee J, Smith B, et al
    Prospective evaluation of pretreatment and intratreatment FDG PET-CT SUV stability in primary head and neck cancer.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25624.
    >> Share

  451. DEN TOOM IJ, Janssen LM, van Es RJJ, Karagozoglu KH, et al
    Depth of invasion in patients with early stage oral cancer staged by sentinel node biopsy.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25665.
    >> Share

  452. RILEY CA, Marino MJ, Hsieh MC, Wu EL, et al
    Detection of laryngeal carcinoma in the U.S. elderly population with gastroesophageal reflux disease.
    Head Neck. 2019 Jan 25. doi: 10.1002/hed.25600.
    >> Share

  453. KLIGERMAN MP, Sethi RKV, Kozin ED, Gray ST, et al
    Morbidity and mortality among patients with head and neck cancer in the emergency department: A national perspective.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25534.
    >> Share

  454. MENNINI FS, Marcellusi A, Fabiano G, Platini F, et al
    Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25481.
    >> Share

  455. BUTTERWORTH CJ
    Primary vs secondary zygomatic implant placement in patients with head and neck cancer-A 10-year prospective study.
    Head Neck. 2019 Jan 21. doi: 10.1002/hed.25645.
    >> Share

  456. SOOD A, Wykes J, Roshan D, Wang LY, et al
    A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 19. doi: 10.1002/hed.25599.
    >> Share

  457. MIRABILE A, Miceli R, Calderone RG, Locati L, et al
    Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25636.
    >> Share

  458. KRAAIJENGA SA, Hamming-Vrieze O, Verheijen S, Lamers E, et al
    Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25573.
    >> Share

  459. HUANG HI, Chen CH, Wang SH, Wang LH, et al
    Effects of APE1 Asp148Glu polymorphisms on OPMD malignant transformation, and on susceptibility to and overall survival of oral cancer in Taiwan.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25576.
    >> Share

  460. FAGAN JJ, Otiti J, Aswani J, Konney A, et al
    African head and neck fellowships: A model for a sustainable impact on head and neck cancer care in developing countries.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25615.
    >> Share

  461. PAVON MA, Arroyo-Solera I, Leon X, Tellez-Gabriel M, et al
    The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25623.
    >> Share

  462. CABEZAS-CAMARERO S, Garcia-Barberan V, Saiz-Pardo Sanz M, Cabrera-Martin MN, et al
    Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25635.
    >> Share

  463. SU WW, Su CW, Chang DC, Chuang SL, et al
    Impact of varying anatomic sites on advanced stage and survival of oral cancer: A 9-year prospective cohort of 27 717 cases.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25579.
    >> Share

  464. BUGTER O, van Iwaarden DLP, Dronkers EAC, de Herdt MJ, et al
    Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25595.
    >> Share

  465. MEHTA V, Ow TJ, Kim S, Tharakan T, et al
    Significant racial differences in the incidence and behavior of the follicular variant of papillary thyroid carcinoma.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25596.
    >> Share

  466. SINGER S, Amdal CD, Hammerlid E, Tomaszewska IM, et al
    International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.
    Head Neck. 2019 Jan 12. doi: 10.1002/hed.25609.
    >> Share

  467. LEE JW, Ban MJ, Park JH, Lee SM, et al
    Visceral adipose tissue volume and CT-attenuation as prognostic factors in patients with head and neck cancer.
    Head Neck. 2019 Jan 12. doi: 10.1002/hed.25605.
    >> Share

  468. BECKHAM TH, Leeman J, Jillian Tsai C, Riaz N, et al
    Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: A series of 9 cases and review of the literature.
    Head Neck. 2019 Jan 11. doi: 10.1002/hed.25577.
    >> Share

  469. CHAN JW, Yeh I, El-Sayed IH, Algazi AP, et al
    Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site.
    Head Neck. 2019 Jan 11. doi: 10.1002/hed.25613.
    >> Share

  470. VAN DAELE DJ, Langmore SE, Krisciunas GP, Lazarus CL, et al
    The impact of time after radiation treatment on dysphagia in patients with head and neck cancer enrolled in a swallowing therapy program.
    Head Neck. 2019 Jan 10. doi: 10.1002/hed.25344.
    >> Share

  471. TESHIMA M, Otsuki N, Shinomiya H, Morita N, et al
    Impact of retropharyngeal lymph node dissection in the surgical treatment of hypopharyngeal cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25608.
    >> Share

  472. XIANG ZZ, Liu F, Yan RN, Zeng YY, et al
    The prognostic value of volumetric reduction of the target lesions after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25620.
    >> Share

  473. IWATA AJ, Olden HA, Kippen KE, Swegal WC, et al
    A flexible model for patient engagement: Achieving quality outcomes and building a research agenda for head and neck cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25584.
    >> Share

  474. WHITE JM, Panchal NH, Wehler CJ, Bestgen SC, et al
    Department of Veterans Affairs Consensus: Preradiation dental treatment guidelines for patients with head and neck cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25519.
    >> Share

  475. INGARFIELD K, McMahon AD, Douglas CM, Savage SA, et al
    Determinants of long-term survival in a population-based cohort study of patients with head and neck cancer from Scotland.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25630.
    >> Share

  476. MONTES DE OCA MK, Nye A, Porter C, Collins J, et al
    Head and neck cancer PEG site metastases: Association with PEG placement method.
    Head Neck. 2019 Jan 7. doi: 10.1002/hed.25564.
    >> Share

  477. DENARO AN, Merlano MC
    Unexpected response with palliative conventional therapy in head and neck squamous cell carcinoma after anti-programmed death-1 progression.
    Head Neck. 2019 Jan 5. doi: 10.1002/hed.25418.
    >> Share

  478. MAYFIELD JD, Mercado CE, Kaye FJ, Mendenhall WM, et al
    Cetuximab-associated pulmonary toxicity in concurrent chemoradiation for the treatment of a squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 5. doi: 10.1002/hed.25528.
    >> Share

    December 2018
  479. LIN CS, Chen YW, Liu SC, Tsao CC, et al
    Treatment outcomes with whole-field versus split-field intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Head Neck. 2018 Dec 31. doi: 10.1002/hed.25328.
    >> Share

  480. GILL A, Givi BB, Moore MG
    AHNS Series - Do you know your guidelines?: Assessment and management of malnutrition in patients with head and neck cancer: A review of the NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines((R)) ).
    Head Neck. 2018 Dec 31. doi: 10.1002/hed.24866.
    >> Share

  481. YANG L, Huang Y, Zhou L, Dai Y, et al
    High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 30. doi: 10.1002/hed.25583.
    >> Share

  482. RAMOS-GARCIA P, Gonzalez-Moles MA, Ayen A, Gonzalez-Ruiz L, et al
    Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Head Neck. 2018 Dec 30. doi: 10.1002/hed.25632.
    >> Share

  483. TIAN YM, Liu MZ, Zeng L, Bai L, et al
    Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25545.
    >> Share

  484. BUGTER O, van de Ven SEM, Hardillo JA, Bruno MJ, et al
    Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25548.
    >> Share

  485. MIRZA AH, Aylin P, Middleton S, King EV, et al
    Impact of social deprivation on the outcome of major head and neck cancer surgery in England: A national analysis.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25461.
    >> Share

  486. ALVES-PAIVA RM, Gutierrez-Rodrigues F, Pereira-Martins DA, Figueiredo DLA, et al
    Short telomere length in peripheral blood leukocytes in head and neck cancer: Findings in a Brazilian cohort.
    Head Neck. 2018 Dec 27. doi: 10.1002/hed.25472.
    >> Share

  487. CHOI SW, Ko H
    Primary Ewing sarcoma of the squamous temporal bone with intracranial and extracranial extension: A rare cause of sudden sensorineural hearing loss.
    Head Neck. 2018 Dec 24. doi: 10.1002/hed.25449.
    >> Share

  488. HOLLOWS R, Wei W, Cazier JB, Mehanna H, et al
    Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25537.
    >> Share

  489. CAO C, Wei Q, Tang X, Jia Y, et al
    PD-1 and PD-L1 in locoregionally advanced nasopharyngeal carcinoma: A substudy of a randomized phase III trial.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25601.
    >> Share

  490. TANDON S, Gairola M, Ahlawat P, Karimi AM, et al
    Failure patterns of head and neck squamous cell carcinoma treated with radical radiotherapy by intensity modulated radiotherapy technique using focal volume and dosimetric method.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25586.
    >> Share

  491. FATTOUH M, Chang GY, Ow TJ, Shifteh K, et al
    Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25420.
    >> Share

  492. DI MAIO P, Iocca O, De Virgilio A, Ferreli F, et al
    Role of palatine tonsillectomy in the diagnostic workup of head and neck squamous cell carcinoma of unknown primary origin: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 21. doi: 10.1002/hed.25522.
    >> Share

  493. KWON DI, Miles BA
    Hypopharyngeal carcinoma: Do you know your guidelines?
    Head Neck. 2018 Dec 20. doi: 10.1002/hed.24752.
    >> Share

  494. VAN DER GEER SJ, van Rijn PV, Kamstra JI, Langendijk JA, et al
    Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25369.
    >> Share

  495. WANG L, Han S, Zhu J, Wang X, et al
    Proton versus photon radiation-induced cell death in head and neck cancer cells.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25357.
    >> Share

  496. KABARRITI R, Baliga S, Ohri N, Guha C, et al
    Radiation therapy for patients with newly diagnosed metastatic head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 16. doi: 10.1002/hed.25476.
    >> Share

  497. IBRAHIM MY, Nunez MI, Harun N, Lee JJ, et al
    PI3-kinase pathway biomarkers in oral cancer and tumor immune cells.
    Head Neck. 2018 Dec 16. doi: 10.1002/hed.25350.
    >> Share

  498. WANG K, Moon DH, Amdur RJ, Dagan R, et al
    Shoulder symptoms and quality of life impact of limited neck dissection after de-intensified chemoradiotherapy: Secondary analysis of two prospective trials.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25535.
    >> Share

  499. EGYUD M, Sridhar P, Devaiah A, Yamada E, et al
    Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25563.
    >> Share

  500. PLASCHKE CC, Johannesen HH, Hansen RH, Hendel HW, et al
    The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25454.
    >> Share

  501. SLAVIK M, Shatokhina T, Sana J, Ahmad P, et al
    Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25533.
    >> Share

  502. KUBOKI A, Kanaya H, Nakayama T, Konno W, et al
    Prognostic value of C-reactive protein/albumin ratio for patients with hypopharyngeal and laryngeal cancer undergoing invasive surgery involving laryngectomy.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25565.
    >> Share

  503. LEE YA, Li S, Chen Y, Li Q, et al
    Tobacco smoking, alcohol drinking, betel quid chewing, and the risk of head and neck cancer in an East Asian population.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25383.
    >> Share

  504. WANG Y, Xie D, Wang Z, Zhang X, et al
    Kinetics of indocyanine green: Optimizing tumor to normal tissue fluorescence in image-guided oral cancer surgery applications.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25541.
    >> Share

  505. ODENTHAL J, Friedl P, Takes RP
    Compatibility of CO2 laser surgery and fluorescence detection in head and neck cancer cells.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25547.
    >> Share

  506. KARABULUT B
    AHNS series: Do you know our guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25491.
    >> Share

  507. PAGEDAR NA, Davis AB, Sperry SM, Charlton ME, et al
    Population analysis of socioeconomic status and otolaryngologist distribution on head and neck cancer outcomes.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25521.
    >> Share

  508. PAKKANEN PP, Aaltonen LM, Sorsa TA, Tervahartiala TI, et al
    Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25459.
    >> Share

  509. RUUSKANEN M, Irjala H, Minn H, Vahlberg T, et al
    Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25450.
    >> Share

  510. ARRESE LC, Schieve HJ, Graham JM, Stephens JA, et al
    Relationship between oral intake, patient perceived swallowing impairment, and objective videofluoroscopic measures of swallowing in patients with head and neck cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25542.
    >> Share

  511. GUEZENNEC C, Robin P, Orlhac F, Bourhis D, et al
    Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25433.
    >> Share

  512. SCHIMANSKY S, Lang S, Beynon R, Penfold C, et al
    Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25543.
    >> Share

  513. ZHU Y, Liu H, Xie N, Liu X, et al
    Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25462.
    >> Share

  514. TAMAKI A
    HED-17-0417-AHNS series: Do you know your guidelines? A review of current knowledge on laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25448.
    >> Share

  515. GAO W, Wong TS, Lv KX, Zhang MJ, et al
    Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25544.
    >> Share

  516. TUMATI V, Hoang L, Sumer BD, Truelson JM, et al
    Association between treatment delays and oncologic outcome in patients treated with surgery and radiotherapy for head and neck cancer.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25457.
    >> Share

  517. SHAHID N, Iqbal A, Siddiqui AJ, Shoaib M, et al
    Plasma metabolite profiling and chemometric analyses of tobacco snuff dippers and patients with oral cancer: Relationship between metabolic signatures.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25511.
    >> Share

  518. RODNER E, Bocklitz T, von Eggeling F, Ernst G, et al
    Fully convolutional networks in multimodal nonlinear microscopy images for automated detection of head and neck carcinoma: A pilot study.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25489.
    >> Share

  519. KIM TH, Lee IJ, Kim JH, Lee CG, et al
    High-dose versus standard-dose radiation therapy for cervical esophageal cancer: A retrospective single-institution study.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25483.
    >> Share

  520. QUATRE R, Jacquet T, Atallah I, Tillement O, et al
    Evaluation of the theranostic properties of gadolinium-based nanoparticles for head and neck cancer.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25460.
    >> Share

  521. PANTVAIDYA G, Sivasanker M, Ranganathan P, Pai P, et al
    Prospective cross-sectional study assessing prevalence and factors affecting trismus after multimodal treatment for oral cancers.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25464.
    >> Share

  522. LADANYI A, Kapuvari B, Papp E, Toth E, et al
    Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25546.
    >> Share

  523. ARROYO-SOLERA I, Pavon MA, Leon X, Lopez M, et al
    Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25437.
    >> Share

  524. MIYAMARU S, Minoda R, Kodama N
    Long-term changes in vocal function after supracricoid partial laryngectomy with cricohyoidoepiglottopexy for laryngeal cancer.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25487.
    >> Share

  525. LUMLEY CJ, Kaffenberger TM, Desale S, Tefera E, et al
    Post-diagnosis aspirin use and survival in veterans with head and neck cancer.
    Head Neck. 2018 Dec 11. doi: 10.1002/hed.25518.
    >> Share

  526. FANG FM, Huang TL, Lin YH, Chien CY, et al
    Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25551.
    >> Share

  527. KUWABARA H, Toriihara A, Yuasa-Nakagawa K, Toda K, et al
    Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25490.
    >> Share

  528. YANG CY, Lin CK, Hsieh CC, Tsao CH, et al
    Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25554.
    >> Share

  529. LEE JH, Chun YS, Chung YS
    Extent of lateral neck dissection for papillary thyroid microcarcinomas.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25570.
    >> Share

  530. RYU HJ, Kim EK, Cho BC, Yoon SO, et al
    Characterization of head and neck squamous cell carcinoma arising in young patients: Particular focus on molecular alteration and tumor immunity.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25507.
    >> Share

  531. MCSPADDEN R, Zender C, Eskander A
    AHNS series: Do you know your guidelines? Guideline recommendations for recurrent and persistent head and neck cancer after primary treatment.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25443.
    >> Share

  532. CHOI JB, Lee SG, Kim MJ, Kim TH, et al
    Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25356.
    >> Share

  533. OKAZAKI E, Kawabe J, Oishi M, Hosono M, et al
    Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography evaluation using metabolic tumor volume of the primary tumor and lymph nodes in advanced hypopharyngeal cancer.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25429.
    >> Share

  534. HUTCHESON KA, Nurgalieva Z, Zhao H, Gunn GB, et al
    Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25412.
    >> Share

  535. ROTMAN A, Kerr SJ, Giddings CEB
    Elective neck dissection in metastatic cutaneous squamous cell carcinoma to the parotid gland: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25561.
    >> Share

  536. DRIESSEN CML, Leijendeckers J, Snik A, van der Graaf WTA, et al
    Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25434.
    >> Share

  537. VILASECA I, Nogues-Sabate A, Aviles-Jurado FX, Berenguer J, et al
    Factors of local recurrence and organ preservation with transoral laser microsurgery in laryngeal carcinomas; CHAID decision-tree analysis.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25422.
    >> Share

  538. VON DER GRUN J, Kohn J, Loutfi-Krauss B, Blanck O, et al
    Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2max ) of >180 Gy for patients with recurrent head and neck cancer.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25428.
    >> Share

    November 2018
  539. PAGEDAR NA, Fowlkes JW, Sheffield AM
    Operative technique: Lateral neck dissection.
    Head Neck. 2018 Nov 26. doi: 10.1002/hed.25348.
    >> Share

  540. WONG ET, Dmytriw AA, Yu E, Waldron J, et al
    (18) F-FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta-analysis of reported studies.
    Head Neck. 2018 Nov 20. doi: 10.1002/hed.25513.
    >> Share

  541. BOSSI P, Miceli R, Benasso M, Corvo R, et al
    Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials.
    Head Neck. 2018 Nov 17. doi: 10.1002/hed.25389.
    >> Share

  542. PARK JC, Gourin CG, Kiess AP, Mehra R, et al
    Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States.
    Head Neck. 2018 Nov 13. doi: 10.1002/hed.25333.
    >> Share

  543. TRUONG AT, Truong DT, Rahlfs TF
    TRS score: A proposed mnemonic for airway assessment and management in patients with head and neck cancers.
    Head Neck. 2018 Nov 2. doi: 10.1002/hed.25502.
    >> Share

    October 2018
  544. ANSCHUETZ L, Visini M, Shelan M, Elicin O, et al
    Risk analysis for tracheostomy dependency in curatively treated laryngeal cancer with organ preservation.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25373.
    >> Share

  545. LEON X, Pardo L, Sansa A, Fernandez A, et al
    Prognostic role of extracapsular spread in planned neck dissection after chemoradiotherapy.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25390.
    >> Share

  546. ZHANG N, Fielding R, Soong I, Chan KK, et al
    Illness perceptions as predictors of psychological distress among head and neck cancer survivors: a longitudinal study.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25343.
    >> Share

  547. KILIC S, Kilic SS, Hsueh WD, Eloy JA, et al
    Radiotherapy modality as a predictor of survival in hypopharyngeal cancer.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25360.
    >> Share

  548. SON HJ, Kim JK, Jung YD, Jang GH, et al
    Comparison of outcomes between hemithyroidectomy alone and hemithyroidectomy with elective unilateral central neck dissection in patients with papillary thyroid microcarcinoma.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25354.
    >> Share

  549. KOGASHIWA Y, Inoue H, Kuba K, Araki R, et al
    Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25353.
    >> Share

  550. HAMILTON SN, Tran E, Berthelet E, Wu J, et al
    Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
    Head Neck. 2018 Oct 8. doi: 10.1002/hed.25352.
    >> Share

    September 2018
  551. SCRIMGER RA, Seikaly H, Vos LJ, Harris J, et al
    Combination of submandibular salivary gland transfer and intensity-modulated radiotherapy to reduce dryness of mouth (xerostomia) in patients with head and neck cancer.
    Head Neck. 2018 Sep 3. doi: 10.1002/hed.25339.
    >> Share

    August 2018
  552. DOMINGUES CSDC, Serambeque BP, Laranjo Candido MS, Marto CMM, et al
    Epithelial-mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer.
    Head Neck. 2018 Aug 18. doi: 10.1002/hed.25381.
    >> Share

  553. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25366.
    >> Share

  554. KARATAS OF
    Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25361.
    >> Share

    July 2018
  555. HONG YT, Hong KH
    Identification of lymphatic channels in the tracheoesophageal groove during central neck dissection for thyroid cancer.
    Head Neck. 2018 Jul 26. doi: 10.1002/hed.25125.
    >> Share

    June 2018
  556. MARIONI G, Cappellesso R, Ottaviano G, Fasanaro E, et al
    Nuclear nonmetastatic protein 23-H1 expression and epithelial-mesenchymal transition in laryngeal carcinoma: A pilot investigation.
    Head Neck. 2018 Jun 28. doi: 10.1002/hed.25188.
    >> Share

  557. LEBO NL, Griffiths R, Hall S, Dimitroulakos J, et al
    Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma.
    Head Neck. 2018 Jun 22. doi: 10.1002/hed.25152.
    >> Share

  558. OOFT ML, van Ipenburg J, van de Loo RJM, de Jong R, et al
    Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
    Head Neck. 2018 Jun 21. doi: 10.1002/hed.25195.
    >> Share

    May 2018
  559. THAM T, Bardash Y, Herman SW, Costantino PD, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 May 14. doi: 10.1002/hed.25324.
    >> Share

  560. WU JS, Tsai YC, Jian JJ, Chen HH, et al
    Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25205.
    >> Share

  561. LANDEEN KC, Spanos WC, Gromer L
    Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25119.
    >> Share

  562. ANDERSON NJ, Jackson JE, Smith JG, Wada M, et al
    Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25316.
    >> Share

  563. TRIVEDI NP
    Oral cancer involving masticator space (T4b): Review of literature and future directions.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25211.
    >> Share

  564. SUCCO G, Crosetti E, Bertolin A, Piazza C, et al
    Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: Prognostic impact of different pathologic tumor subcategories.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25176.
    >> Share

  565. ALAHMAD YM, Aljaber M, Saleh AI, Yalcin HC, et al
    Effect of cell-phone radiofrequency on angiogenesis and cell invasion in human head and neck cancer cells.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25210.
    >> Share

  566. SONG JSA, Moolman N, Burrell S, Rajaraman M, et al
    Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25204.
    >> Share

  567. MULCAHY CF, Mohamed ASR, Kanwar A, Hutcheson KA, et al
    Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25200.
    >> Share

  568. ONO T, Azuma K, Kawahara A, Sasada T, et al
    Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25189.
    >> Share

    April 2018
  569. NAIR D, Mair M, Singhvi H, Mishra A, et al
    Perineural invasion: Independent prognostic factor in oral cancer that warrants adjuvant treatment.
    Head Neck. 2018 Apr 29. doi: 10.1002/hed.25170.
    >> Share

  570. HO JC, Phan J
    Reirradiation of head and neck cancer using modern highly conformal techniques.
    Head Neck. 2018 Apr 23. doi: 10.1002/hed.25180.
    >> Share

  571. BERNSTEIN LJ, Pond GR, Gan HK, Tirona K, et al
    Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort.
    Head Neck. 2018 Apr 17. doi: 10.1002/hed.25198.
    >> Share

  572. FAN CY, Jen YM, Su YC, Chao HL, et al
    Association between nasopharyngeal carcinoma and risk of optic neuropathy: A population-based cohort study.
    Head Neck. 2018 Apr 16. doi: 10.1002/hed.25177.
    >> Share

    March 2018
  573. SHINGLER E, Robles LA, Perry R, Penfold C, et al
    Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia.
    Head Neck. 2018 Mar 30. doi: 10.1002/hed.25138.
    >> Share

  574. HAQUE SU, Niu L, Kuhnell D, Hendershot J, et al
    Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 25. doi: 10.1002/hed.25136.
    >> Share

  575. HEGDE JV, Demanes DJ, Veruttipong D, Chin RK, et al
    Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25137.
    >> Share

  576. KIM HK, Lee I, Lee J, Chang HS, et al
    BRAF(wild) papillary thyroid carcinoma has two distinct mRNA expression patterns with different clinical behaviors.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25151.
    >> Share

  577. RHOTEN BA, Murphy BA, Dietrich MS, Ridner SH, et al
    Depressive symptoms, social anxiety, and perceived neck function in patients with head and neck cancer.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25129.
    >> Share

  578. LUCIONI M, Lionello M, Salis G, Bertolin A, et al
    Bocca's hemipharyngo-total laryngectomy for hypopharyngeal carcinoma to avoid reconstruction with a pedicled flap.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25124.
    >> Share

  579. CONDELLO V, Macerola E, Ugolini C, De Napoli L, et al
    Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25155.
    >> Share

  580. MCEWEN SE, Dunphy C, Rios JN, Davis AM, et al
    Evaluation of a rehabilitation planning consult for survivors of head and neck cancer.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25113.
    >> Share

  581. PAYNE K, Spruce R, Beggs A, Sharma N, et al
    Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25140.
    >> Share

  582. WANG CI, Yu CJ, Huang Y, Yi JS, et al
    Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1beta-induced matrix metalloproteinase expression in oral cancer.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25145.
    >> Share

  583. KIM H, Vargo JA, Beriwal S, Clump DA, et al
    Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancer.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25142.
    >> Share

  584. SUZUKI S, Yasunaga H, Matsui H, Fushimi K, et al
    Postoperative mechanical bowel obstruction after pharyngolaryngectomy for hypopharyngeal cancer: Retrospective analysis using a Japanese inpatient database.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25139.
    >> Share

  585. YU F, Lu Y, Petersson F, Wang DY, et al
    Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25131.
    >> Share

  586. DAHER T, Tur MK, Brobeil A, Etschmann B, et al
    Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25041.
    >> Share

  587. WANG X, Li Y, Gao Y, Ouyang D, et al
    Second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after radiotherapy predictors and prognostic factors.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25130.
    >> Share

  588. MIZUSHIMA T, Ohnishi S, Shimizu Y, Hatanaka Y, et al
    Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25126.
    >> Share

  589. VUONG HG, Odate T, Duong UNP, Mochizuki K, et al
    Prognostic importance of solid variant papillary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25123.
    >> Share

  590. LU J, Chen XM, Huang HR, Zhao FP, et al
    Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 1. doi: 10.1002/hed.25104.
    >> Share

    February 2018
  591. PENFOLD CM, Thomas SJ, Waylen A, Ness AR, et al
    Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from head and neck 5000.
    Head Neck. 2018 Feb 27. doi: 10.1002/hed.25116.
    >> Share

  592. HAMSTRA DA, Lee KC, Eisbruch A, Sunkara P, et al
    Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer.
    Head Neck. 2018 Feb 23. doi: 10.1002/hed.25115.
    >> Share

  593. DANILOVIC DLS, de Mello ES, Frazzato EST, Wakamatsu A, et al
    Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
    Head Neck. 2018 Feb 22. doi: 10.1002/hed.25105.
    >> Share

  594. MORISADA M, Chamberlin M, Allen C
    Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer.
    Head Neck. 2018 Feb 20. doi: 10.1002/hed.25101.
    >> Share

  595. OSBORN VW, Givi B, Rineer J, Roden D, et al
    Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25103.
    >> Share

  596. CHAN SL, Ng LS, Goh X, Siow CH, et al
    Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25112.
    >> Share

  597. GINGERICH MA, Smith JD, Michmerhuizen NL, Ludwig M, et al
    Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.
    Head Neck. 2018 Feb 10. doi: 10.1002/hed.25057.
    >> Share

  598. YOSHIDA EJ, Luu M, David JM, Kim S, et al
    Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25100.
    >> Share

  599. KIRKE DN, Qureshi MM, Kamran SC, Ezzat W, et al
    Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25087.
    >> Share

  600. MURTHY SP, Balasubramanian D, Subramaniam N, Nair G, et al
    Prevalence of adverse pathological features in 1 to 4 cm low-risk differentiated thyroid carcinoma.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25099.
    >> Share

  601. HALL SF, Griffiths RJ
    Evaluation of treatment outcomes in patients with supraglottic laryngeal cancer in Ontario, Canada: A population-based study.
    Head Neck. 2018 Feb 7. doi: 10.1002/hed.25073.
    >> Share

  602. BACK LJJ, Aro K, Tapiovaara L, Vikatmaa P, et al
    Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma: Review and meta-analysis.
    Head Neck. 2018 Feb 5. doi: 10.1002/hed.25093.
    >> Share

  603. GUTTMANN DM, Kobie J, Grover S, Lin A, et al
    National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25091.
    >> Share

  604. TALMI YP, Takes RP, Alon EE, Nixon IJ, et al
    Prognostic value of lymph node ratio in head and neck squamous cell carcinoma.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25080.
    >> Share

  605. LIN PJ, Twu CW, Liu YC, Lin TY, et al
    Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25084.
    >> Share

  606. TIRELLI G, Bergamini PR, Scardoni A, Gatto A, et al
    Intraoperative monitoring of marginal mandibular nerve during neck dissection.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25078.
    >> Share

    January 2018
  607. VALLS-MATEUS M, Nogues-Sabate A, Blanch JL, Bernal-Sprekelsen M, et al
    Narrow band imaging for head and neck malignancies: Lessons learned from mistakes.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25088.
    >> Share

  608. NAKAYAMA M, Gosho M, Hirose Y, Nishimura B, et al
    Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25085.
    >> Share

  609. ZENGA J, Pipkorn P, Graboyes EM, Martin EJ, et al
    Oncologic outcomes of extended neck dissections in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Head Neck. 2018 Jan 29. doi: 10.1002/hed.25060.
    >> Share

  610. AEBERHARD C, Mayer C, Meyer S, Mueller SA, et al
    Effect of preoperative immunonutrition on postoperative short-term outcomes of patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 24. doi: 10.1002/hed.25072.
    >> Share

  611. VASAN K, Low TH, Gupta R, Ashford B, et al
    Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25066.
    >> Share

  612. LAM JKS, Sundaresan P, Gebski V, Veness MJ, et al
    Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25069.
    >> Share

  613. BAUMEISTER P, Baumuller K, Harreus U, Reiter M, et al
    Evaluation of margins in head and neck squamous cell carcinoma from the surgeon's perspective.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25061.
    >> Share

  614. MASCARELLA MA, Mannard E, Daniela Silva Wurzba S, Zeitouni A, et al
    Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25075.
    >> Share

  615. ESKANDER A, Strigenz D, Seim N, Ozer E, et al
    Submental artery island flap with simultaneous level I neck dissection.
    Head Neck. 2018 Jan 13. doi: 10.1002/hed.25044.
    >> Share

  616. REN Y, Deschler DG, Sajed D, Durand ML, et al
    Case of late-onset, relapsing surgical site infection related to a venous coupler placed during free flap reconstruction for major head and neck cancer.
    Head Neck. 2018 Jan 12. doi: 10.1002/hed.25043.
    >> Share

  617. OKER N, Verillaud B, Wassef M, Froelich S, et al
    Ethmoidal adenocarcinoma treated by exclusive endoscopic approach: Focus on learning curve and modification of management.
    Head Neck. 2018;40:126-136.
    >> Share

  618. LEE DJ, Chin CJ, Hong CJ, Perera S, et al
    Outpatient versus inpatient thyroidectomy: A systematic review and meta-analysis.
    Head Neck. 2018;40:192-202.
    >> Share

  619. KNIGGE MA, Thibeault SL
    Swallowing outcomes after cricopharyngeal myotomy: A systematic review.
    Head Neck. 2018;40:203-212.
    >> Share

  620. MATTAVELLI D, Schreiber A, Villaret AB, Accorona R, et al
    Complications and donor site morbidity of 3-layer reconstruction with iliotibial tract of the anterior skull base: Retrospective analysis of 186 patients.
    Head Neck. 2018;40:63-69.
    >> Share

  621. LANSU J, Klop WM, Heemsbergen W, Navran A, et al
    Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy.
    Head Neck. 2018;40:86-93.
    >> Share

    December 2017
  622. AVINCSAL MO, Shinomiya H, Teshima M, Kubo M, et al
    Impact of alcohol dehydrogenase-aldehyde dehydrogenase polymorphism on clinical outcome in patients with hypopharyngeal cancer.
    Head Neck. 2017 Dec 29. doi: 10.1002/hed.25050.
    >> Share

  623. DEJACO D, Steinbichler T, Schartinger VH, Fischer N, et al
    Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.
    Head Neck. 2017 Dec 22. doi: 10.1002/hed.25040.
    >> Share

  624. SON HJ, Roh JL, Choi SH, Nam SY, et al
    Nutritional and hematologic markers as predictors of risk of surgical site infection in patients with head and neck cancer undergoing major oncologic surgery.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25031.
    >> Share

  625. SANABRIA A, Kowalski LP, Shah JP, Nixon IJ, et al
    Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25029.
    >> Share

    November 2017
  626. FULCHER CD, Haigentz M Jr, Ow TJ
    AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.
    Head Neck. 2017 Nov 24. doi: 10.1002/hed.25025.
    >> Share

  627. ESKANDER A, Ghanem T, Agrawal A
    AHNS Series: Do you know your guidelines? Guideline recommendations for head and neck cancer of unknown primary site.
    Head Neck. 2017 Nov 21. doi: 10.1002/hed.25026.
    >> Share

  628. CAO C, Hu Q, Chen X
    Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25016.
    >> Share

  629. WONG DJY, Donaldson C, Lai LT, Coleman A, et al
    Safety and effectiveness of endovascular embolization or stent-graft reconstruction for treatment of acute carotid blowout syndrome in patients with head and neck cancer: Case series and systematic review of observational studies.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25018.
    >> Share

  630. LECHELT LA, Rieger JM, Cowan K, Debenham BJ, et al
    Top 10 research priorities in head and neck cancer: Results of an Alberta priority setting partnership of patients, caregivers, family members, and clinicians.
    Head Neck. 2017 Nov 17. doi: 10.1002/hed.24998.
    >> Share

  631. MAYS AC, Bartels HG, Wistermayer PR, Rohlfing ML, et al
    Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer population.
    Head Neck. 2017 Nov 13. doi: 10.1002/hed.24992.
    >> Share

  632. LEONG YH, Soon YY, Lee KM, Wong LC, et al
    Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24993.
    >> Share

  633. DAVIDI ES, Dreifuss T, Motiei M, Shai E, et al
    Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24935.
    >> Share

  634. KAMSTRA JI, van Leeuwen M, Roodenburg JLN, Dijkstra PU, et al
    Exercise therapy for trismus secondary to head and neck cancer: A systematic review.
    Head Neck. 2017;39:2352-2362.
    >> Share

    October 2017
  635. CHAN JYW, Wong STS, Wei WI
    Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement.
    Head Neck. 2017 Oct 30. doi: 10.1002/hed.24976.
    >> Share

  636. TAMAKI A, Miles BA, Lango M, Kowalski L, et al
    AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24862.
    >> Share

  637. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24986.
    >> Share

  638. PENG S, Wu C, Sun W, Liu D, et al
    Snail-mediated cancer stem cell-like phenotype in human CNE2 nasopharyngeal carcinoma cell.
    Head Neck. 2017 Oct 12. doi: 10.1002/hed.24982.
    >> Share

  639. HUANG WB, Wong STS, Chan JYW
    Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2017 Oct 9. doi: 10.1002/hed.24973.
    >> Share

  640. LIU JC
    Head and Neck Cancer, Multimodality Management, 2nd ed, Editor: Jacques Bernier Jeffrey C. Liu Springer, Switzerland, 2016, USD $329, 878 pages.
    Head Neck. 2017 Oct 5. doi: 10.1002/hed.24920.
    >> Share

    September 2017
  641. FAN CY, Chao HL, Lin CS, Huang WY, et al
    Risk of depressive disorder among patients with head and neck cancer: A nationwide population-based study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24961.
    >> Share

  642. LECHIEN JR, Nassri A, Kindt N, Brown DN, et al
    Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24939.
    >> Share

  643. ONG HS, Gokavarapu S, Al-Qamachi L, Yin MY, et al
    Justification of routine venous thromboembolism prophylaxis in head and neck cancer reconstructive surgery.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24914.
    >> Share

  644. BURNS CL, Kularatna S, Ward EC, Hill AJ, et al
    Cost analysis of a speech pathology synchronous telepractice service for patients with head and neck cancer.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24916.
    >> Share

  645. LOMBARDI D, Paderno A, Giordano D, Barbieri D, et al
    Therapeutic lateral neck dissection in well-differentiated thyroid cancer: Analysis on factors predicting distribution of positive nodes and prognosis.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24936.
    >> Share

  646. AVILES-JURADO FX, Flores JC, Guma J, Ceperuelo-Mallafre V, et al
    Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24919.
    >> Share

  647. QIU J, Lv B, Fu M, Wang X, et al
    18 F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24925.
    >> Share

  648. LIU H, Zhang Y, Zhang T, Li F, et al
    Correlation between the pathology and clinical presentations in patients with adenoid cystic carcinoma of the external auditory canal.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24915.
    >> Share

  649. KAWAKITA D, Lee YA, Li Q, Chen Y, et al
    Impact of oral hygiene on head and neck cancer risk in a Chinese population.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24929.
    >> Share

  650. LUCIONI M, D'Ascanio L, De Nardi E, Lionello M, et al
    Management of paratracheal lymph nodes in laryngeal cancer with subglottic involvement.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24905.
    >> Share

  651. CHENG SJ, Chang CF, Ko HH, Lee JJ, et al
    Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24958.
    >> Share

  652. ITO M, Kodaira T, Tachibana H, Tomita N, et al
    Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24909.
    >> Share

  653. ZHANG H, Kim S, Chen Z, Nannapaneni S, et al
    Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24911.
    >> Share

  654. DA FONSECA FL, Yamanaka PK, Mazoti L, Arakawa-Sugueno L, et al
    Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24895.
    >> Share

    May 2017
  655. ZHANG D, Li F, Wu CW, Liu X, et al
    Percutaneous probe stimulation for intraoperative neuromonitoring in total endoscopic thyroidectomy: A preliminary experience.
    Head Neck. 2017;39:1001-1007.
    >> Share

  656. LOPEZ F, Triantafyllou A, Snyderman CH, Hunt JL, et al
    Nasal juvenile angiofibroma: Current perspectives with emphasis on management.
    Head Neck. 2017;39:1033-1045.
    >> Share

  657. WELLER MA, Ward MC, Berriochoa C, Reddy CA, et al
    Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2017;39:940-946.
    >> Share

  658. MORISOD B, Venara-Vulpe II, Alzuphar S, Monnier Y, et al
    Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.
    Head Neck. 2017;39:965-973.
    >> Share

  659. LANSAAT L, van den Boer C, Muller SH, van der Noort V, et al
    Ex vivo humidifying capacity and patient acceptability of stoma cloths in laryngectomized individuals.
    Head Neck. 2017;39:921-931.
    >> Share

    April 2017
  660. GARCIA-OLMO DC, Contreras JD, Picazo MG, Lopez-Torres J, et al
    Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx.
    Head Neck. 2017;39:647-655.
    >> Share

  661. VAN LOON Y, Stiggelbout AM, Hakkesteegt MM, Langeveld TP, et al
    Utility approach to decision-making in extended T1 and limited T2 glottic carcinoma.
    Head Neck. 2017;39:779-785.
    >> Share

  662. DUEK I, Amit M, Sviri GE, Gil Z, et al
    Combined endoscopic transcervical-transoral robotic approach for resection of parapharyngeal space tumors.
    Head Neck. 2017;39:786-790.
    >> Share

  663. ZHOU L, Luo W
    Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation.
    Head Neck. 2017;39:656-661.
    >> Share

  664. TURRI-ZANONI M, Salzano G, Lambertoni A, Giovannardi M, et al
    Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
    Head Neck. 2017;39:730-736.
    >> Share

  665. ALMADORI G, Lauriola L, Coli A, Bussu F, et al
    Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab.
    Head Neck. 2017;39:684-693.
    >> Share

  666. TURRI-ZANONI M, Battaglia P, Karligkiotis A, Lepera D, et al
    Transnasal endoscopic partial maxillectomy: Operative nuances and proposal for a comprehensive classification system based on 1378 cases.
    Head Neck. 2017;39:754-766.
    >> Share

    March 2017
  667. SIDDIQUI F, Smith RV, Yom SS, Beitler JJ, et al
    ACR appropriateness criteria((R)) nasal cavity and paranasal sinus cancers.
    Head Neck. 2017;39:407-418.
    >> Share

  668. IWAKI S, Maeda T, Saito M, Otsuki N, et al
    Role of immediate recurrent laryngeal nerve reconstruction in surgery for thyroid cancers with fixed vocal cords.
    Head Neck. 2017;39:427-431.
    >> Share

  669. NISHIO N, Fujii M, Hayashi Y, Hiramatsu M, et al
    Preoperative surgical simulation and validation of the line of resection in anterolateral craniofacial resection of advanced sinonasal sinus carcinoma.
    Head Neck. 2017;39:512-519.
    >> Share

  670. LOMBARDI D, Mattavelli D, Redaelli De Zinis LO, Accorona R, et al
    Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease.
    Head Neck. 2017;39:E45-E50.
    >> Share

  671. SIVARS L, Landin D, Haeggblom L, Tertipis N, et al
    Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Head Neck. 2017;39:419-426.
    >> Share

  672. MATTHEIS S, Hasskamp P, Holtmann L, Schafer C, et al
    Flex Robotic System in transoral robotic surgery: The first 40 patients.
    Head Neck. 2017;39:471-475.
    >> Share

  673. YU Y, Mabray M, Silveira W, Shen PY, et al
    Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Head Neck. 2017;39:432-438.
    >> Share

    February 2017
  674. GOOI Z, Richmon J, Agrawal N, Blair E, et al
    AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines.
    Head Neck. 2017;39:201-205.
    >> Share

  675. FRISCH T
    Versatility of the facial artery myomucosal island flap in neopharyngeal reconstruction.
    Head Neck. 2017;39:E29-E33.
    >> Share

  676. MCDOWELL LJ, Jacobson MC, Levin W
    High-dose intravenous steroid regimen for radiation-induced hypoglossal nerve palsy.
    Head Neck. 2017;39:E23-E28.
    >> Share

  677. MEHTA V, Flores JM, Thompson RW, Nathan CA, et al
    Primary payer status, individual patient characteristics, and hospital-level factors affecting length of stay and total cost of hospitalization in total laryngectomy.
    Head Neck. 2017;39:311-319.
    >> Share

  678. GAVRIEL H, Eviatar E, Abu Eta R
    Hyperbaric oxygen therapy for maxillary bone radiation-induced injury: A 15-year single-center experience.
    Head Neck. 2017;39:275-278.
    >> Share

  679. WEAVER AN, Cooper TS, Wei S, Carroll WR, et al
    DNA-PkCS expression in oropharyngeal squamous cell carcinoma: Correlations with human papillomavirus status and recurrence after transoral robotic surgery.
    Head Neck. 2017;39:206-214.
    >> Share

    January 2017
  680. HOFSTEDE TM, Jacob RF, Montgomery P, Wesley P, et al
    Surgical preparation of nasal defects to enhance the implant-retained facial prostheses: A case report.
    Head Neck. 2017;39:E4-E11.
    >> Share

  681. ALLENSWORTH JJ, O'Dell KD, Schindler JS
    Bilateral vocal fold paralysis and dysphagia secondary to diffuse idiopathic skeletal hyperostosis.
    Head Neck. 2017;39:E1-E3.
    >> Share

  682. BEECH NM, Porceddu S, Batstone MD
    Radiotherapy-associated dental extractions and osteoradionecrosis.
    Head Neck. 2017;39:128-132.
    >> Share

  683. ANSARIN M, Cattaneo A, De Benedetto L, Zorzi S, et al
    Retrospective analysis of factors influencing oncologic outcome in 590 patients with early-intermediate glottic cancer treated by transoral laser microsurgery.
    Head Neck. 2017;39:71-81.
    >> Share

  684. RACKLEY TP, Namelo WC, Palaniappan N, Cole N, et al
    Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil.
    Head Neck. 2017;39:17-23.
    >> Share

  685. BAUMEISTER P, Rauch J, Jacobi C, Kisser U, et al
    Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.
    Head Neck. 2017;39:7-16.
    >> Share

    April 2016
  686. SABA NF, Salama JK, Beitler JJ, Busse PM, et al
    ACR Appropriateness criteria(R) for nasopharyngeal carcinoma.
    Head Neck. 2016 Apr 30. doi: 10.1002/hed.24423.
    >> Share

  687. ROSKO AJ, Spector ME, Griffin GR, Vainshtein JM, et al
    Neurologic late effects associated with radiologic evidence of vertebral osteoradionecrosis after salvage laryngectomy: A syndrome associated with survivors of laryngeal and hypopharyngeal cancer.
    Head Neck. 2016 Apr 15. doi: 10.1002/hed.24348.
    >> Share

  688. OMURA G, Ando M, Saito Y, Kobayashi K, et al
    Association of the upregulated expression of focal adhesion kinase with poor prognosis and tumor dissemination in hypopharyngeal cancer.
    Head Neck. 2016 Apr 9. doi: 10.1002/hed.24176.
    >> Share

  689. CHOI YS, Park SG, Song EK, Cho SH, et al
    Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
    Head Neck. 2016 Apr 4. doi: 10.1002/hed.24438.
    >> Share

    March 2016
  690. HARRIS BN, Bhuskute AA, Rao S, Farwell DG, et al
    Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
    Head Neck. 2016 Mar 25. doi: 10.1002/hed.24443.
    >> Share

  691. PERETTI G, Piazza C, Penco S, Santori G, et al
    Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
    Head Neck. 2016 Mar 11. doi: 10.1002/hed.24424.
    >> Share

    February 2016
  692. EDSON MA, Garden AS, Takiar V, Glisson BS, et al
    Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy.
    Head Neck. 2016 Feb 27. doi: 10.1002/hed.24387.
    >> Share

  693. XIONG J, Krishnaswamy G, Raynor S, Loh KS, et al
    Risk of swallowing-related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity-modulated radiotherapy.
    Head Neck. 2016 Feb 18. doi: 10.1002/hed.24296.
    >> Share

  694. VENGALIL S, Giuliani ME, Huang SH, McNiven A, et al
    Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy.
    Head Neck. 2016 Feb 1. doi: 10.1002/hed.24374.
    >> Share

    December 2015
  695. LEWIS GD, Holliday EB, Kocak-Uzel E, Hernandez M, et al
    Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes.
    Head Neck. 2015 Dec 26. doi: 10.1002/hed.24341.
    >> Share

  696. FLORIE M, Baijens L, Kremer B, Kross K, et al
    Relationship between swallow-specific quality of life and fiber-optic endoscopic evaluation of swallowing findings in patients with head and neck cancer.
    Head Neck. 2015 Dec 23. doi: 10.1002/hed.24333.
    >> Share

  697. OUYOUNG LM, Swanson MS, Villegas BC, Damodar D, et al
    ABCLOVE: Voice therapy outcomes for patients with head and neck cancer.
    Head Neck. 2015 Dec 22. doi: 10.1002/hed.24322.
    >> Share

  698. SENGAR M, Chorghe S, Jadhav K, Singh S, et al
    Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine.
    Head Neck. 2015 Dec 15. doi: 10.1002/hed.24297.
    >> Share

    November 2015
  699. DRIESSEN CM, Uijen MJ, van der Graaf WT, van Opstal CC, et al
    Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer.
    Head Neck. 2015 Nov 28. doi: 10.1002/hed.24281.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016